"Term","Jaccard","Odds_Ratio","Fold_Enrichment","PValue","FDR","Genes"
"GO:0002574~thrombocyte differentiation",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"8314"
"GO:0061444~endocardial cushion cell development",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"182"
"GO:1903903~regulation of establishment of T cell polarity",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"2934"
"GO:0043363~nucleate erythrocyte differentiation",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"8314"
"GO:0043045~epigenetic programming of gene expression",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"1786"
"GO:1903909~regulation of receptor clustering",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"2934"
"GO:0014820~tonic smooth muscle contraction",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"4638"
"GO:0072287~metanephric distal tubule morphogenesis",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"5310"
"GO:1903906~regulation of plasma membrane raft polarization",0.0232558139534884,Inf,459.186046511628,0.00217776652317059,0.0270248822087941,"2934"
"GO:0072393~microtubule anchoring at microtubule organizing center",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"23299"
"GO:0018364~peptidyl-glutamine methylation",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"51504"
"GO:0061097~regulation of protein tyrosine kinase activity",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"57826"
"GO:0090322~regulation of superoxide metabolic process",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"6464"
"GO:1904908~negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"GO:0046619~lens placode formation involved in camera-type eye formation",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"10818"
"GO:0032014~positive regulation of ARF protein signal transduction",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"9448"
"GO:0070661~leukocyte proliferation",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"8314"
"GO:0072070~loop of Henle development",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"182"
"GO:0007161~calcium-independent cell-matrix adhesion",0.0444444444444444,474.307742057255,229.593023255814,2.77187371520251e-05,0.00182019707298298,"2335, 5310"
"GO:0070571~negative regulation of neuron projection regeneration",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"9448"
"GO:1905931~negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"1786"
"GO:1903923~positive regulation of protein processing in phagocytic vesicle",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"2934"
"GO:0014891~striated muscle atrophy",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"2934"
"GO:0035128~post-embryonic forelimb morphogenesis",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"GO:0070476~rRNA (guanine-N7)-methylation",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"51504"
"GO:0141119~chromosomal DNA methylation maintenance following DNA replication",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"1786"
"GO:0005168~neurotrophin TRKA receptor binding",0.0652173913043478,490.699947984625,229.593023255814,1.9153357815375e-07,0.00010061897305677,"10818, 5335, 6464"
"GO:0031752~D5 dopamine receptor binding",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"10672"
"GO:0141106~tRNA methyltransferase activator activity",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"51504"
"GO:0050429~calcium-dependent phospholipase C activity",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"5335"
"GO:0036313~phosphatidylinositol 3-kinase catalytic subunit binding",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"2934"
"R-HSA-9670621~Defective Inhibition of DNA Recombination at Telomere",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"R-HSA-9670613~Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"R-HSA-9006821~Alternative Lengthening of Telomeres (ALT)",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"R-HSA-9673013~Diseases of Telomere Maintenance",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"R-HSA-9670615~Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations",0.0227272727272727,462.790047171316,229.593023255814,0.00435090043927167,0.0376759290785283,"546"
"GO:1905460~negative regulation of vascular associated smooth muscle cell apoptotic process",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"1786"
"GO:0072017~distal tubule development",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"182"
"GO:0006213~pyrimidine nucleoside metabolic process",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"2079"
"GO:0019046~release from viral latency",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"3725"
"GO:1903940~negative regulation of TORC2 signaling",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"6198"
"GO:0071801~regulation of podosome assembly",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"2934"
"GO:0072164~mesonephric tubule development",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5310"
"GO:1905049~negative regulation of metallopeptidase activity",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"7077"
"GO:0036303~lymph vessel morphogenesis",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5310"
"GO:0016476~regulation of embryonic cell shape",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"989"
"GO:0032984~protein-containing complex disassembly",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"54541"
"GO:0071941~nitrogen cycle metabolic process",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5310"
"GO:0014878~response to electrical stimulus involved in regulation of muscle adaptation",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"6198"
"GO:0150102~negative regulation of monocyte activation",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"2335"
"GO:1902263~apoptotic process involved in embryonic digit morphogenesis",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"10018"
"GO:0061309~cardiac neural crest cell development involved in outflow tract morphogenesis",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"182"
"GO:0061519~macrophage homeostasis",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"8314"
"GO:0097017~renal protein absorption",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"2934"
"GO:0036344~platelet morphogenesis",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"8314"
"GO:0072237~metanephric proximal tubule development",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5310"
"GO:0043201~response to L-leucine",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"6198"
"GO:0048070~regulation of developmental pigmentation",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"10018"
"GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"2335"
"GO:0003886~DNA (cytosine-5-)-methyltransferase activity",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"1786"
"GO:0051719~DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"1786"
"GO:0051720~DNA (cytosine-5-)-methyltransferase activity, acting on CpNpG substrates",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"1786"
"GO:0009008~DNA-methyltransferase activity",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"1786"
"R-HSA-167021~PLC-gamma1 signalling",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5335"
"R-HSA-111446~Activation of BIM and translocation to mitochondria ",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"10018"
"R-HSA-9034793~Activated NTRK3 signals through PLCG1",0.0222222222222222,232.303284308067,153.062015503876,0.00651941136877121,0.0431705559545522,"5335"
"GO:1903926~cellular response to bisphenol A",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"1786"
"GO:0140958~target-directed miRNA degradation",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"6921"
"GO:0071635~negative regulation of transforming growth factor beta production",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"2335"
"GO:0002085~inhibition of neuroepithelial cell differentiation",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"182"
"GO:1902110~positive regulation of mitochondrial membrane permeability involved in apoptotic process",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"10018"
"GO:0062043~positive regulation of cardiac epithelial to mesenchymal transition",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"182"
"GO:0071864~positive regulation of cell proliferation in bone marrow",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"6464"
"GO:0045639~positive regulation of myeloid cell differentiation",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"182"
"GO:0060414~aorta smooth muscle tissue morphogenesis",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"4638"
"GO:1904313~response to methamphetamine hydrochloride",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"6198"
"GO:1902174~positive regulation of keratinocyte apoptotic process",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"2934"
"GO:0072385~minus-end-directed organelle transport along microtubule",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"23299"
"GO:0072218~metanephric ascending thin limb development",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"5310"
"GO:0048408~epidermal growth factor binding",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"6464"
"GO:0004687~myosin light chain kinase activity",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"4638"
"R-HSA-1251932~PLCG1 events in ERBB2 signaling",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"5335"
"R-HSA-9026527~Activated NTRK2 signals through PLCG1",0.0217391304347826,154.89689649842,114.796511627907,0.00868330891264424,0.0501278199499169,"5335"
"GO:0090312~positive regulation of protein deacetylation",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"25855"
"GO:0072177~mesonephric duct development",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"5310"
"GO:0160040~mitocytosis",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"5310"
"GO:0090114~COPII-coated vesicle budding",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"10484"
"GO:0160221~Rho-activating G protein-coupled receptor signaling pathway",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"10672"
"GO:0033299~secretion of lysosomal enzymes",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"4074"
"GO:0070192~chromosome organization involved in meiotic cell cycle",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"546"
"GO:0004459~L-lactate dehydrogenase activity",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"3939"
"GO:0019211~phosphatase activator activity",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"10818"
"GO:0015616~DNA translocase activity",0.0212765957446809,116.638327084796,91.8372093023256,0.0108426026524121,0.0581360021617923,"546"
"R-HSA-5655291~Signaling by FGFR4 in disease",0.0384615384615385,106.234871088136,83.4883720930233,0.000251637860997698,0.00843789933898664,"10818, 5335"
"68.Mitogen_signaling_in_growth_control",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"4638"
"101.Gprot_coupled_Rec_MAP_Kinase",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"6464"
"GO:0010571~positive regulation of nuclear cell cycle DNA replication",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"546"
"GO:0007044~cell-substrate junction assembly",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"2335"
"GO:0051127~positive regulation of actin nucleation",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"2934"
"GO:0045602~negative regulation of endothelial cell differentiation",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"182"
"GO:0014732~skeletal muscle atrophy",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"6198"
"GO:0061156~pulmonary artery morphogenesis",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"182"
"GO:0060527~prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"10818"
"GO:0051702~biological process involved in interaction with symbiont",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"2335"
"GO:0010646~regulation of cell communication",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"9448"
"GO:0120183~positive regulation of focal adhesion disassembly",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"9448"
"GO:0007185~cell surface receptor protein tyrosine phosphatase signaling pathway",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"10818"
"GO:0048633~positive regulation of skeletal muscle tissue growth",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"6198"
"GO:0070087~chromo shadow domain binding",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"546"
"GO:0019208~phosphatase regulator activity",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"4659"
"GO:0004111~creatine kinase activity",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"9448"
"GO:0017020~myosin phosphatase regulator activity",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"4659"
"GO:0140950~histone H2A deubiquitinase activity",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"8314"
"GO:0008349~MAP kinase kinase kinase kinase activity",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"9448"
"R-HSA-8952158~RUNX3 regulates BCL2L11 (BIM) transcription",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"10018"
"R-HSA-1566977~Fibronectin matrix formation",0.0208333333333333,93.5504034605654,76.531007751938,0.0129973021501804,0.0628335834008719,"2335"
"WP4560:MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement",0.0517241379310345,97.7808637870833,76.531007751938,7.67332733571252e-06,0.00100776365675691,"3725, 4638, 5335"
"WP3301:MFAP5 mediated ovarian cancer cell motility and invasiveness",0.037037037037037,87.0319143270927,70.6440071556351,0.000355882057544401,0.0112174024537995,"3725, 5335"
"77.IkBa_Kinase_JNK_MEKK1",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"3725"
"GO:0061073~ciliary body morphogenesis",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"182"
"GO:0070358~actin polymerization-dependent cell motility",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"10094"
"GO:0061668~mitochondrial ribosome assembly",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"51335"
"GO:2000726~negative regulation of cardiac muscle cell differentiation",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"10818"
"GO:0061101~neuroendocrine cell differentiation",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"182"
"GO:0000212~meiotic spindle organization",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"546"
"GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"54453"
"GO:0060428~lung epithelium development",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"5310"
"GO:0034405~response to fluid shear stress",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"5310"
"GO:1901166~neural crest cell migration involved in autonomic nervous system development",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"2335"
"GO:2000210~positive regulation of anoikis",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"25855"
"GO:2000144~positive regulation of DNA-templated transcription initiation",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"3725"
"R-HSA-2660826~Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"182"
"R-HSA-2660825~Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"182"
"R-HSA-9027277~Erythropoietin activates Phospholipase C gamma (PLCG)",0.0204081632653061,77.7938553143945,65.5980066445183,0.0151474169486782,0.0680123336499054,"5335"
"R-HSA-5637810~Constitutive Signaling by EGFRvIII",0.0357142857142857,73.6853341644433,61.2248062015504,0.000477748477441246,0.0121440580717323,"5335, 6464"
"R-HSA-5637812~Signaling by EGFRvIII in Cancer",0.0357142857142857,73.6853341644433,61.2248062015504,0.000477748477441246,0.0121440580717323,"5335, 6464"
"WP3958:GPR40 pathway",0.0357142857142857,73.6853341644433,61.2248062015504,0.000477748477441246,0.0121440580717323,"5310, 5335"
"GO:0031670~cellular response to nutrient",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"6198"
"GO:0035148~tube formation",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10018"
"GO:0048066~developmental pigmentation",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10018"
"GO:0030223~neutrophil differentiation",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"8314"
"GO:0051045~negative regulation of membrane protein ectodomain proteolysis",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"7077"
"GO:0046620~regulation of organ growth",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10018"
"GO:0070307~lens fiber cell development",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10818"
"GO:0071895~odontoblast differentiation",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"203068"
"GO:0008595~anterior/posterior axis specification, embryo",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10818"
"GO:1903896~positive regulation of IRE1-mediated unfolded protein response",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"10018"
"GO:1902857~positive regulation of non-motile cilium assembly",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"989"
"GO:0086003~cardiac muscle cell contraction",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"2934"
"GO:0046822~regulation of nucleocytoplasmic transport",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"4659"
"R-HSA-9665348~Signaling by ERBB2 ECD mutants",0.0350877192982456,68.5192045682577,57.3982558139535,0.000545243683262163,0.013220062228018,"5335, 6464"
"WP3634:Insulin signaling in adipocytes normal condition ",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"6198"
"WP3635:Insulin signaling in adipocytes diabetic condition ",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"6198"
"WP5211:Glucose metabolism in triple negative breast cancer cells",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"3939"
"WP4860:Hijack of ubiquitination by SARS CoV 2",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"6921"
"WP4928:MAPK pathway in congenital thyroid cancer",0.0350877192982456,68.5192045682577,57.3982558139535,0.000545243683262163,0.013220062228018,"3725, 6464"
"WP3585:Cytosine methylation",0.02,66.7986130001934,57.3982558139535,0.0172929565712944,0.0722909802555966,"1786"
"GO:1900242~regulation of synaptic vesicle endocytosis",0.0344827586206897,63.8526745153714,54.0218878248974,0.00061708895264644,0.0138933169910113,"10094, 4638"
"GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity",0.0344827586206897,63.8526745153714,54.0218878248974,0.00061708895264644,0.0138933169910113,"10818, 6464"
"92.Ancient_Host_Defense_Pathways",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"3725"
"114.Genomic_reformatting_Brain_Ischemia",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"3725"
"GO:0007127~meiosis I",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"10018"
"GO:0070234~positive regulation of T cell apoptotic process",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"10018"
"GO:0010558~negative regulation of macromolecule biosynthetic process",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"546"
"GO:1900015~regulation of cytokine production involved in inflammatory response",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"8314"
"GO:0033028~myeloid cell apoptotic process",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"8314"
"GO:0046324~regulation of D-glucose import",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"6198"
"GO:0072205~metanephric collecting duct development",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"5310"
"GO:0035726~common myeloid progenitor cell proliferation",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"8314"
"GO:0072006~nephron development",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"182"
"GO:0006089~lactate metabolic process",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"3939"
"GO:0032886~regulation of microtubule-based process",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"57542"
"R-HSA-111453~BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"10018"
"R-HSA-212718~EGFR interacts with phospholipase C-gamma",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"5335"
"WP3300:Dual hijack model of Vif in HIV infection",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"6921"
"WP3670:Interactions between LOXL4 and oxidative stress pathway",0.0338983050847458,59.8745637935395,51.0206718346253,0.000693265905810281,0.0151748203827361,"2335, 5310"
"WP2456:HIF1A and PPARG in hypertrophic cardiomyopathy",0.0196078431372549,58.4780153167127,51.0206718346253,0.0194339305221199,0.076378739408631,"3939"
"R-HSA-201556~Signaling by ALK",0.0441176470588235,58.895616096536,49.1985049833887,3.03417627358445e-05,0.00191274472286763,"10818, 1786, 5335"
"GO:0050678~regulation of epithelial cell proliferation",0.0333333333333333,56.3661862593444,48.3353733170135,0.000773756219175064,0.0158368805379208,"10818, 182"
"GO:0001953~negative regulation of cell-matrix adhesion",0.0333333333333333,56.3661862593444,48.3353733170135,0.000773756219175064,0.0158368805379208,"182, 9448"
"R-HSA-1236382~Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants",0.0333333333333333,56.3661862593444,48.3353733170135,0.000773756219175064,0.0158368805379208,"5335, 6464"
"R-HSA-5637815~Signaling by Ligand-Responsive EGFR Variants in Cancer",0.0333333333333333,56.3661862593444,48.3353733170135,0.000773756219175064,0.0158368805379208,"5335, 6464"
"WP3972:PDGFR beta pathway",0.0434782608695652,56.6377773443209,47.5020048115477,3.37913870081423e-05,0.00197241577499379,"3725, 5335, 6464"
"54.T-cell_anergy",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"5335"
"GO:0044539~long-chain fatty acid import into cell",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"6198"
"GO:0048806~genitalia development",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"5310"
"GO:0032060~bleb assembly",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"4638"
"GO:0003170~heart valve development",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"9782"
"GO:0002262~myeloid cell homeostasis",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"10018"
"GO:0032486~Rap protein signal transduction",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"57826"
"GO:0000470~maturation of LSU-rRNA",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"51504"
"GO:0033622~integrin activation",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"2335"
"GO:0071476~cellular hypotonic response",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"4638"
"GO:2000234~positive regulation of rRNA processing",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"51504"
"GO:2000271~positive regulation of fibroblast apoptotic process",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"10018"
"GO:0043583~ear development",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"10018"
"GO:0045159~myosin II binding",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"2934"
"GO:0004629~phospholipase C activity",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"5335"
"GO:1905394~retromer complex binding",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"4074"
"R-HSA-450341~Activation of the AP-1 family of transcription factors",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"3725"
"R-HSA-74749~Signal attenuation",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"6464"
"R-HSA-418890~Role of second messengers in netrin-1 signaling",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"5335"
"KW-0483~Metalloprotease inhibitor",0.0192307692307692,51.924757172867,45.9186046511628,0.0215703482859806,0.079242118645001,"7077"
"R-HSA-8862803~Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",0.032258064516129,50.3774600332659,43.7320044296788,0.000947603912327817,0.0179930574196222,"10018, 3725"
"R-HSA-8863678~Neurodegenerative Diseases",0.032258064516129,50.3774600332659,43.7320044296788,0.000947603912327817,0.0179930574196222,"10018, 3725"
"GO:0033762~response to glucagon",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"6198"
"GO:0031509~subtelomeric heterochromatin formation",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"546"
"GO:0061179~negative regulation of insulin secretion involved in cellular response to glucose stimulus",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"9448"
"GO:0072711~cellular response to hydroxyurea",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"546"
"GO:0060009~Sertoli cell development",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"546"
"GO:0070198~protein localization to chromosome, telomeric region",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"546"
"GO:0090557~establishment of endothelial intestinal barrier",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"57826"
"GO:0070242~thymocyte apoptotic process",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"10018"
"GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"10018"
"GO:0035520~monoubiquitinated protein deubiquitination",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"8314"
"GO:0032794~GTPase activating protein binding",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"203068"
"GO:0016504~peptidase activator activity",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"2335"
"R-HSA-9013700~NOTCH4 Activation and Transmission of Signal to the Nucleus",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"182"
"R-HSA-9028731~Activated NTRK2 signals through FRS2 and FRS3",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"10818"
"R-HSA-9665686~Signaling by ERBB2 TMD/JMD mutants",0.0317460317460317,47.8670408296104,41.7441860465116,0.00104092492464913,0.0188562951867474,"5335, 6464"
"R-HSA-9701898~STAT3 nuclear events downstream of ALK signaling",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"1786"
"R-HSA-5655332~Signaling by FGFR3 in disease",0.0317460317460317,47.8670408296104,41.7441860465116,0.00104092492464913,0.0188562951867474,"10818, 5335"
"R-HSA-210990~PECAM1 interactions",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"5335"
"R-HSA-9634285~Constitutive Signaling by Overexpressed ERBB2",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"6464"
"R-HSA-9839383~TGFBR3 PTM regulation",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"7077"
"R-HSA-1660517~Synthesis of PIPs at the late endosome membrane",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"55697"
"KW-0481~Metalloenzyme inhibitor",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"7077"
"WP3676:BDNF TrkB signaling",0.0410958904109589,49.0386641396528,41.7441860465116,5.01504102679364e-05,0.00263456821940892,"5335, 6198, 6464"
"WP5166:Glyoxylate metabolism",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"3939"
"WP5049:Glycolysis in senescence",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"3939"
"WP2333:Trans sulfuration pathway",0.0188679245283019,46.7523057007139,41.7441860465116,0.0237022193284784,0.0813827835766491,"1786"
"R-HSA-9006115~Signaling by NTRK2 (TRKB)",0.03125,45.5974622415798,39.9292214357937,0.00113848656194273,0.0199361646846861,"10818, 5335"
"GO:0072015~podocyte development",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"182"
"GO:0030042~actin filament depolymerization",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"2934"
"GO:0003215~cardiac right ventricle morphogenesis",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"182"
"GO:2001214~positive regulation of vasculogenesis",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"54453"
"GO:0051549~positive regulation of keratinocyte migration",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"9448"
"GO:0046479~glycosphingolipid catabolic process",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"4074"
"GO:0061061~muscle structure development",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"4638"
"GO:0001759~organ induction",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"10818"
"GO:0035497~cAMP response element binding",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"3725"
"GO:0035254~glutamate receptor binding",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"5335"
"GO:0140296~general transcription initiation factor binding",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"3725"
"GO:0034452~dynactin binding",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"23299"
"R-HSA-9734009~Defective Intrinsic Pathway for Apoptosis",0.0307692307692308,43.54331386024,38.265503875969,0.00124027077943459,0.0205754394567254,"10018, 3725"
"R-HSA-9857377~Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"529"
"R-HSA-264870~Caspase-mediated cleavage of cytoskeletal proteins",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"2934"
"R-HSA-5627123~RHO GTPases activate PAKs",0.0307692307692308,43.54331386024,38.265503875969,0.00124027077943459,0.0205754394567254,"4638, 4659"
"R-HSA-9831926~Nephron development",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"182"
"R-HSA-9020558~Interleukin-2 signaling",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"6464"
"R-HSA-9700645~ALK mutants bind TKIs",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"2335"
"R-HSA-170968~Frs2-mediated activation",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"10818"
"R-HSA-5654708~Downstream signaling of activated FGFR3",0.0307692307692308,43.54331386024,38.265503875969,0.00124027077943459,0.0205754394567254,"10818, 5335"
"R-HSA-9673324~WNT5:FZD7-mediated leishmania damping",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"3725"
"R-HSA-9664420~Killing mechanisms",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"3725"
"WP1539:Angiogenesis",0.0307692307692308,43.54331386024,38.265503875969,0.00124027077943459,0.0205754394567254,"5335, 7077"
"WP5150:Spina bifida",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"1786"
"WP4629:Aerobic glycolysis",0.0185185185185185,42.5349470573671,38.265503875969,0.0258295530960305,0.0841061480978184,"3939"
"GO:1904707~positive regulation of vascular associated smooth muscle cell proliferation",0.038961038961039,43.2972073121539,37.2313010685104,7.09879216298373e-05,0.00319648469967496,"10818, 1786, 3725"
"WP127:IL5 signaling",0.038961038961039,43.2972073121539,37.2313010685104,7.09879216298373e-05,0.00319648469967496,"3725, 6198, 6464"
"GO:0048015~phosphatidylinositol-mediated signaling",0.0303030303030303,41.6151355873898,36.7348837209302,0.0013462595876698,0.0212170511016761,"5335, 6198"
"R-HSA-9664565~Signaling by ERBB2 KD Mutants",0.0303030303030303,41.6151355873898,36.7348837209302,0.0013462595876698,0.0212170511016761,"5335, 6464"
"R-HSA-9006335~Signaling by Erythropoietin",0.0303030303030303,41.6151355873898,36.7348837209302,0.0013462595876698,0.0212170511016761,"5335, 6464"
"R-HSA-1643713~Signaling by EGFR in Cancer",0.0303030303030303,41.6151355873898,36.7348837209302,0.0013462595876698,0.0212170511016761,"5335, 6464"
"GO:1904753~negative regulation of vascular associated smooth muscle cell migration",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"10672"
"GO:0043922~negative regulation by host of viral transcription",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3725"
"GO:0051693~actin filament capping",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"2934"
"GO:0010762~regulation of fibroblast migration",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"10672"
"GO:0002011~morphogenesis of an epithelial sheet",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"182"
"GO:0043086~negative regulation of catalytic activity",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"4659"
"GO:0032495~response to muramyl dipeptide",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"182"
"GO:0008276~protein methyltransferase activity",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"51504"
"R-HSA-1227990~Signaling by ERBB2 in Cancer",0.0298507462686567,39.9439730855881,35.3220035778175,0.00145643505236621,0.0220705927166264,"5335, 6464"
"R-HSA-5654716~Downstream signaling of activated FGFR4",0.0298507462686567,39.9439730855881,35.3220035778175,0.00145643505236621,0.0220705927166264,"10818, 5335"
"R-HSA-5654227~Phospholipase C-mediated cascade; FGFR3",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"5335"
"WP3876:BMP2 WNT4 FOXO1 pathway in primary endometrial stromal cell differentiation",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"10018"
"WP4236:Krebs cycle disorders",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3939"
"WP2881:Estrogen receptor pathway",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3725"
"WP2814:Mammary gland development puberty stage 2 of 4",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"2335"
"WP5314:Lactate shuttle in glial cells",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3939"
"WP4919:Neuroinflammation",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3725"
"WP4628:Aerobic glycolysis augmented",0.0181818181818182,39.0076547082218,35.3220035778175,0.0279523590159046,0.0876003871619762,"3939"
"WP3680:Physico chemical features and toxicity associated pathways",0.0480769230769231,42.3131692801368,34.7868217054264,3.12047179163064e-07,0.000122946588590247,"2335, 3725, 4638, 5335, 6464"
"R-HSA-8853659~RET signaling",0.0375,39.8090187083508,34.4389534883721,8.98552190121881e-05,0.00363107244008227,"10818, 5335, 6464"
"WP2526:PDGF pathway",0.0375,39.8090187083508,34.4389534883721,8.98552190121881e-05,0.00363107244008227,"3725, 5335, 6464"
"R-HSA-354192~Integrin signaling",0.0294117647058824,38.3337378530623,34.0137812230835,0.00157077929426833,0.0229217422941379,"2335, 6464"
"GO:0030705~cytoskeleton-dependent intracellular transport",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"203068"
"GO:0051014~actin filament severing",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"2934"
"GO:0050982~detection of mechanical stimulus",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"5310"
"GO:0055119~relaxation of cardiac muscle",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"2934"
"GO:0023051~regulation of signaling",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"9448"
"GO:0097284~hepatocyte apoptotic process",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"2934"
"GO:0006090~pyruvate metabolic process",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"3939"
"GO:0060411~cardiac septum morphogenesis",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"182"
"GO:0043394~proteoglycan binding",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"2335"
"GO:0140318~protein transporter activity",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"4074"
"GO:0008191~metalloendopeptidase inhibitor activity",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"7077"
"R-HSA-156581~Methylation",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"51504"
"R-HSA-169893~Prolonged ERK activation events",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"10818"
"R-HSA-180336~SHC1 events in EGFR signaling",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"6464"
"R-HSA-9027284~Erythropoietin activates RAS",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"6464"
"R-HSA-5654696~Downstream signaling of activated FGFR2",0.0289855072463768,36.8563498158734,32.7990033222591,0.0016892744890016,0.0244247394006103,"10818, 5335"
"R-HSA-1250347~SHC1 events in ERBB4 signaling",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"6464"
"R-HSA-8849471~PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"63916"
"R-HSA-8941856~RUNX3 regulates NOTCH signaling",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"182"
"R-HSA-8983432~Interleukin-15 signaling",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"6464"
"WP3969:H19 Rb E2F1 and CDK beta catenin in colorectal cancer",0.0178571428571429,36.0142494849797,32.7990033222591,0.0300706464962575,0.089249225759137,"182"
"R-HSA-5654687~Downstream signaling of activated FGFR1",0.0285714285714286,35.4566730534643,31.6680032076985,0.00181190286692704,0.0254960617703305,"10818, 5335"
"3.T_cell_receptor",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"3725"
"GO:0035332~positive regulation of hippo signaling",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"9448"
"GO:0071549~cellular response to dexamethasone stimulus",0.028169014084507,34.2110480049204,30.6124031007752,0.00193864671299624,0.0263365832893146,"54541, 6198"
"GO:0042491~inner ear auditory receptor cell differentiation",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"182"
"GO:0022408~negative regulation of cell-cell adhesion",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"182"
"GO:0070372~regulation of ERK1 and ERK2 cascade",0.028169014084507,34.2110480049204,30.6124031007752,0.00193864671299624,0.0263365832893146,"10818, 2335"
"GO:0001702~gastrulation with mouth forming second",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"10818"
"GO:0048011~neurotrophin TRK receptor signaling pathway",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"54541"
"GO:0060674~placenta blood vessel development",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"5310"
"GO:0045820~negative regulation of glycolytic process",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"54541"
"R-HSA-2691232~Constitutive Signaling by NOTCH1 HD Domain Mutants",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"182"
"R-HSA-9674555~Signaling by CSF3 (G-CSF)",0.028169014084507,34.2110480049204,30.6124031007752,0.00193864671299624,0.0263365832893146,"6464, 6921"
"R-HSA-354194~GRB2:SOS provides linkage to MAPK signaling for Integrins ",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"2335"
"R-HSA-5654219~Phospholipase C-mediated cascade: FGFR1",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"5335"
"R-HSA-5654228~Phospholipase C-mediated cascade; FGFR4",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"5335"
"R-HSA-2691230~Signaling by NOTCH1 HD Domain Mutants in Cancer",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"182"
"R-HSA-372708~p130Cas linkage to MAPK signaling for integrins",0.0175438596491228,33.4187241900897,30.6124031007752,0.032184424926172,0.0923909903162971,"2335"
"WP5365:4p16 3 copy number variation",0.028169014084507,34.2110480049204,30.6124031007752,0.00193864671299624,0.0263365832893146,"10818, 5335"
"R-HSA-2871796~FCERI mediated MAPK activation",0.0277777777777778,33.0180257167176,29.6249062265566,0.00206948836660667,0.0270248822087941,"3725, 5335"
"GO:0044027~negative regulation of gene expression via chromosomal CpG island methylation",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"1786"
"GO:0090162~establishment of epithelial cell polarity",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"5310"
"GO:0030031~cell projection assembly",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"2934"
"GO:0031167~rRNA methylation",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"51504"
"GO:0002456~T cell mediated immunity",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"182"
"GO:0045446~endothelial cell differentiation",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"182"
"GO:0042813~Wnt receptor activity",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"5310"
"GO:0005159~insulin-like growth factor receptor binding",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"6464"
"R-HSA-9034015~Signaling by NTRK3 (TRKC)",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"5335"
"R-HSA-1660516~Synthesis of PIPs at the early endosome membrane",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"55697"
"R-HSA-9614657~FOXO-mediated transcription of cell death genes",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"10018"
"WP2435:Quercetin and Nf kB AP 1 induced apoptosis",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"3725"
"WP5312:Metabolic pathways of fibroblasts",0.0273972602739726,31.942046700735,28.6991279069767,0.0022044102214574,0.0271418008516943,"3939, 5335"
"WP4962:Airway smooth muscle cell contraction",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"4638"
"WP4970:Galanin receptor pathway",0.0172413793103448,31.2058813176999,28.6991279069767,0.0342937036756995,0.0958277960867064,"10018"
"GO:0008327~methyl-CpG binding",0.027027027027027,30.9120805408769,27.8294573643411,0.00234339472540511,0.0279787127821095,"1786, 2079"
"GO:0071889~14-3-3 protein binding",0.027027027027027,30.9120805408769,27.8294573643411,0.00234339472540511,0.0279787127821095,"4659, 54541"
"R-HSA-187687~Signalling to ERKs",0.027027027027027,30.9120805408769,27.8294573643411,0.00234339472540511,0.0279787127821095,"10818, 6464"
"67.Ikaros_and_signaling_inhibitors",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"3725"
"GO:0003281~ventricular septum development",0.0266666666666667,29.9469969097868,27.0109439124487,0.00248642438032047,0.0292433195775004,"10818, 9782"
"GO:0051290~protein heterotetramerization",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"5310"
"GO:0019752~carboxylic acid metabolic process",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"3939"
"GO:0090110~COPII-coated vesicle cargo loading",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"10484"
"GO:0035909~aorta morphogenesis",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"182"
"R-HSA-4655427~SUMOylation of DNA methylation proteins",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"1786"
"R-HSA-5654221~Phospholipase C-mediated cascade; FGFR2",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"5335"
"WP3859:TGF beta signaling in thyroid cells for epithelial mesenchymal transition",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"2335"
"WP3967:miR 509 3p alteration of YAP1 ECM axis",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"2335"
"WP3413:NOTCH1 regulation of endothelial cell calcification",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"182"
"WP3678:Amplification and expansion of oncogenic pathways as metastatic traits",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"182"
"WP1946:Cori cycle",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"3939"
"WP5483:Hallmark of cancer non mutational epigenetic reprogramming",0.0169491525423729,29.2595753291552,27.0109439124487,0.0363984920958901,0.0985636143352625,"1786"
"WP304:Kit receptor signaling",0.032258064516129,29.4436861027621,25.9916630100921,0.000208891844785738,0.00731585660849605,"5335, 6198, 6464"
"GO:0034314~Arp2/3 complex-mediated actin nucleation",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"10094"
"GO:0072520~seminiferous tubule development",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"546"
"GO:0097401~synaptic vesicle lumen acidification",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"529"
"GO:2000737~negative regulation of stem cell differentiation",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"182"
"GO:0051642~centrosome localization",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"23299"
"GO:1905564~positive regulation of vascular endothelial cell proliferation",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"5335"
"GO:0043923~positive regulation by host of viral transcription",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"3725"
"GO:0030695~GTPase regulator activity",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"54453"
"R-HSA-9700206~Signaling by ALK in cancer",0.0390625,30.3325499831442,25.5103359173127,1.47656865921591e-06,0.000387845367820713,"10818, 1786, 2335, 3725, 5335"
"R-HSA-9725370~Signaling by ALK fusions and activated point mutants",0.0390625,30.3325499831442,25.5103359173127,1.47656865921591e-06,0.000387845367820713,"10818, 1786, 2335, 3725, 5335"
"R-HSA-5654710~PI-3K cascade:FGFR3",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"10818"
"R-HSA-1660514~Synthesis of PIPs at the Golgi membrane",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"55697"
"R-HSA-210993~Tie2 Signaling",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"6464"
"WP3877:MYD88 distinct input output pathway",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"3725"
"WP1471:Target of rapamycin signaling",0.025974025974026,28.188685667936,25.5103359173127,0.0027845494197475,0.0320324809162194,"54541, 6198"
"WP5353:Macrophage stimulating protein MSP signaling",0.0413793103448276,31.1248120334781,25.5103359173127,1.20384469530725e-07,9.48629619902116e-05,"2335, 3725, 3939, 5335, 6198, 6464"
"WP5052:Nephrogenesis",0.0166666666666667,27.5444327449798,25.5103359173127,0.0384987995188366,0.101123513402811,"182"
"WP49:IL2 signaling",0.0256410256410256,27.3854624591793,24.8208673790069,0.0029396100767828,0.0332208624011421,"6198, 6464"
"GO:0043249~erythrocyte maturation",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"8314"
"GO:0009395~phospholipid catabolic process",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"5335"
"GO:0035994~response to muscle stretch",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"2934"
"GO:0043392~negative regulation of DNA binding",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"3725"
"GO:0030414~peptidase inhibitor activity",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"7077"
"R-HSA-5655302~Signaling by FGFR1 in disease",0.0253164556962025,26.6270352725686,24.1676866585067,0.00309864642954815,0.0332208624011421,"10818, 5335"
"R-HSA-5218921~VEGFR2 mediated cell proliferation",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"5335"
"R-HSA-5654741~Signaling by FGFR3",0.0253164556962025,26.6270352725686,24.1676866585067,0.00309864642954815,0.0332208624011421,"10818, 5335"
"R-HSA-167044~Signalling to RAS",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"6464"
"KW-0117~Actin capping",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"2934"
"WP3287:Overview of nanoparticle effects",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577066,0.10488056584614,"2335"
"WP524:G13 signaling",0.0253164556962025,26.6270352725686,24.1676866585067,0.00309864642954815,0.0332208624011421,"10672, 6198"
"WP4829:mBDNF and proBDNF regulation of GABA neurotransmission",0.0253164556962025,26.6270352725686,24.1676866585067,0.00309864642954815,0.0332208624011421,"5335, 6464"
"R-HSA-76009~Platelet Aggregation (Plug Formation)",0.025,25.9096028742188,23.5480023852117,0.00326164124784207,0.0340420305072788,"2335, 6464"
"R-HSA-5654743~Signaling by FGFR4",0.025,25.9096028742188,23.5480023852117,0.00326164124784207,0.0340420305072788,"10818, 5335"
"hsa05100_Bacterial_invasion_of_epithelial_cells",0.0341880341880342,27.183664957863,23.5480023852117,2.47358399028056e-05,0.00182019707298298,"10094, 2335, 63916, 6464"
"GO:0001502~cartilage condensation",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"5310"
"GO:0034067~protein localization to Golgi apparatus",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"23299"
"GO:0046328~regulation of JNK cascade",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"9448"
"GO:0001825~blastocyst formation",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"9782"
"GO:0070131~positive regulation of mitochondrial translation",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"51335"
"GO:0051016~barbed-end actin filament capping",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"2934"
"GO:0001892~embryonic placenta development",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"5310"
"GO:0042288~MHC class I protein binding",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"203068"
"GO:0005104~fibroblast growth factor receptor binding",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"10818"
"GO:0008093~cytoskeletal anchor activity",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"23299"
"R-HSA-5625900~RHO GTPases activate CIT",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"4659"
"R-HSA-5627117~RHO GTPases Activate ROCKs",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"4659"
"R-HSA-5654720~PI-3K cascade:FGFR4",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"10818"
"R-HSA-5654689~PI-3K cascade:FGFR1",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"10818"
"R-HSA-5654706~FRS-mediated FGFR3 signaling",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"10818"
"WP3927:BMP signaling in eyelid development",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"3725"
"WP5142:Calcium mediated T cell apoptosis involved in inclusion body myositis",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"5335"
"WP5492:AMPK regulation of mammary milk protein synthesis",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"6198"
"WP4206:Hereditary leiomyomatosis and renal cell carcinoma pathway",0.0161290322580645,24.6417681215538,22.9593023255814,0.0426860086067848,0.106613549230258,"3939"
"hsa01521_EGFR_tyrosine_kinase_inhibitor_resistance",0.0336134453781513,26.4686336187788,22.9593023255814,2.73399415145654e-05,0.00182019707298298,"10018, 5335, 6198, 6464"
"GO:0014911~positive regulation of smooth muscle cell migration",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"6198"
"GO:0060236~regulation of mitotic spindle organization",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"5310"
"GO:0038202~TORC1 signaling",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"6198"
"GO:0008154~actin polymerization or depolymerization",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"2934"
"GO:0045445~myoblast differentiation",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"182"
"GO:0003184~pulmonary valve morphogenesis",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"182"
"GO:0048278~vesicle docking",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"8675"
"GO:0090200~positive regulation of release of cytochrome c from mitochondria",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"10018"
"GO:0048545~response to steroid hormone",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"3725"
"GO:0001709~cell fate determination",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"182"
"GO:0045948~positive regulation of translational initiation",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"6198"
"GO:1902455~negative regulation of stem cell population maintenance",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"25855"
"R-HSA-5620916~VxPx cargo-targeting to cilium",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"5310"
"KW-0011~Acute phase",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"2335"
"WP3657:Hematopoietic stem cell gene regulation by GABP alpha beta complex",0.0158730158730159,23.4112031923931,21.8660022148394,0.0447729288415076,0.108694664255265,"1786"
"WP4806:EGFR tyrosine kinase inhibitor resistance",0.032520325203252,25.1448455974946,21.8660022148394,3.31443141106924e-05,0.00197241577499379,"10018, 5335, 6198, 6464"
"R-HSA-5655253~Signaling by FGFR2 in disease",0.0238095238095238,23.3756887861243,21.3574905354246,0.00395286242989457,0.0376759290785283,"10818, 5335"
"WP364:IL6 signaling",0.0238095238095238,23.3756887861243,21.3574905354246,0.00395286242989457,0.0376759290785283,"6198, 6464"
"hsa04012_ErbB_signaling_pathway",0.032,24.5303025025902,21.3574905354246,3.63627279201986e-05,0.00204670211436547,"3725, 5335, 6198, 6464"
"GO:0030971~receptor tyrosine kinase binding",0.0285714285714286,23.7455924225969,21.1932021466905,0.00038247930978432,0.0115920652350017,"5335, 63916, 6464"
"GO:0061640~cytoskeleton-dependent cytokinesis",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"989"
"GO:0006939~smooth muscle contraction",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"4638"
"GO:0018149~peptide cross-linking",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"2335"
"GO:0007041~lysosomal transport",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"4074"
"GO:0030879~mammary gland development",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"10018"
"GO:0030490~maturation of SSU-rRNA",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"51504"
"R-HSA-1250196~SHC1 events in ERBB2 signaling",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"6464"
"R-HSA-5654712~FRS-mediated FGFR4 signaling",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"10818"
"R-HSA-5654693~FRS-mediated FGFR1 signaling",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"10818"
"R-HSA-5654695~PI-3K cascade:FGFR2",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"10818"
"WP2911:miRNA targets in ECM and membrane receptors",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"2335"
"WP4141:PI3K AKT mTOR vitamin D3 signaling",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"3939"
"WP4864:Host pathogen interaction of human coronaviruses apoptosis",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"10018"
"WP4537:Hippo YAP signaling",0.015625,22.3000355379625,20.8720930232558,0.0468554052185008,0.110545087761014,"9448"
"WP5300:TROP2 regulatory signaling",0.0232558139534884,22.2905850295352,20.4082687338501,0.00432177972276118,0.0376759290785283,"2335, 3725"
"WP673:ErbB signaling",0.0310077519379845,23.3547613738225,20.4082687338501,4.34784636659278e-05,0.00236282961163801,"10018, 3725, 6198, 6464"
"GO:0002862~negative regulation of inflammatory response to antigenic stimulus",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"5335"
"GO:0031929~TOR signaling",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"6198"
"GO:2000353~positive regulation of endothelial cell apoptotic process",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"5335"
"GO:0060395~SMAD protein signal transduction",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"3725"
"GO:0048754~branching morphogenesis of an epithelial tube",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"5310"
"GO:0031683~G-protein beta/gamma-subunit complex binding",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"10672"
"GO:0005158~insulin receptor binding",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"6464"
"WP3612:Photodynamic therapy induced NFE2L2 NRF2 survival signaling",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"3725"
"WP5181:Roles of ceramides in development of insulin resistance",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"6198"
"WP4585:Cancer immunotherapy by PD 1 blockade",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"3725"
"WP4925:Unfolded protein response",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"10018"
"WP4659:Gastrin signaling",0.0326797385620915,23.4002601435621,19.9646107178969,4.95356266512211e-06,0.000780681476023245,"182, 3725, 5335, 6198, 6464"
"WP712:Estrogen signaling",0.0153846153846154,21.2809219812043,19.9646107178969,0.0489334469756174,0.113077877468582,"3725"
"hsa05120_Epithelial_cell_signaling_in_Helicobacter_pylori_infection",0.0272727272727273,21.960850755639,19.6794019933555,0.00047570866566222,0.0121440580717323,"3725, 529, 5335"
"WP2034:Leptin signaling",0.027027027027027,21.6264371409425,19.4022273173927,0.00049594420131211,0.0124064771629823,"5335, 6198, 6464"
"GO:1904706~negative regulation of vascular associated smooth muscle cell proliferation",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"10672"
"GO:0006911~phagocytosis, engulfment",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"2934"
"GO:0038095~Fc-epsilon receptor signaling pathway",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"5335"
"GO:0046961~proton-transporting ATPase activity, rotational mechanism",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"529"
"GO:0044389~ubiquitin-like protein ligase binding",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"3725"
"R-HSA-5654700~FRS-mediated FGFR2 signaling",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"10818"
"R-HSA-428930~Thromboxane signalling through TP receptor",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"10672"
"KW-0133~Cell shape",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"2335"
"WP2865:IL1 and megakaryocytes in obesity",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"7077"
"WP2035:Follicle stimulating hormone FSH signaling",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"6198"
"WP1528:Physiological and pathological hypertrophy of the heart",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"3725"
"WP5074:Kallmann syndrome",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"10818"
"WP4288:MTHFR deficiency",0.0151515151515152,20.3490038271081,19.1327519379845,0.051007063331973,0.115498752602284,"1786"
"hsa01522_Endocrine_resistance",0.0296296296296296,21.8375531498188,19.1327519379845,5.59929063605279e-05,0.0028466071104578,"182, 3725, 6198, 6464"
"R-HSA-5654736~Signaling by FGFR1",0.0222222222222222,20.3783397293088,18.7422876127195,0.0051055522184533,0.0427997356185234,"10818, 5335"
"WP286:IL3 signaling",0.0222222222222222,20.3783397293088,18.7422876127195,0.0051055522184533,0.0427997356185234,"3725, 6464"
"WP2037:Prolactin signaling",0.0263157894736842,20.7166453966958,18.6156505342552,0.000559940168024425,0.0133706924970681,"3725, 6198, 6464"
"hsa04666_Fc_gamma_R-mediated_phagocytosis",0.0289855072463768,21.1479973036153,18.5529715762274,6.3150336186272e-05,0.00311015405717389,"10094, 2934, 5335, 6198"
"GO:0046597~host-mediated suppression of symbiont invasion",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"2934"
"GO:0097150~neuronal stem cell population maintenance",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"182"
"GO:0001932~regulation of protein phosphorylation",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"2335"
"GO:0071108~protein K48-linked deubiquitination",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"8314"
"GO:0071385~cellular response to glucocorticoid stimulus",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"10018"
"GO:0140467~integrated stress response signaling",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"3725"
"GO:0070840~dynein complex binding",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"23299"
"R-HSA-9013507~NOTCH3 Activation and Transmission of Signal to the Nucleus",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"182"
"R-HSA-9705462~Inactivation of CSF3 (G-CSF) signaling",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"6921"
"R-HSA-1227986~Signaling by ERBB2",0.021978021978022,19.9547198871959,18.3674418604651,0.00531096806737021,0.0431705559545522,"5335, 6464"
"R-HSA-166208~mTORC1-mediated signalling",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"6198"
"WP395:IL4 signaling",0.021978021978022,19.9547198871959,18.3674418604651,0.00531096806737021,0.0431705559545522,"6198, 6464"
"WP3668:Hypothesized pathways in pathogenesis of cardiovascular disease",0.0149253731343284,19.5026516422402,18.3674418604651,0.0530762634879854,0.117933942025848,"6464"
"WP2018:RANKL RANK signaling",0.021978021978022,19.9547198871959,18.3674418604651,0.00531096806737021,0.0431705559545522,"3725, 5335"
"WP69:T cell receptor signaling",0.0260869565217391,20.428847679749,18.3674418604651,0.000582388618181184,0.0134977126801992,"3725, 5335, 6464"
"hsa05110_Vibrio_cholerae_infection",0.021978021978022,19.9547198871959,18.3674418604651,0.00531096806737021,0.0431705559545522,"529, 5335"
"R-HSA-6811440~Retrograde transport at the Trans-Golgi-Network",0.0217391304347826,19.5412479221203,18.0072959416325,0.00552013972570124,0.0431705559545522,"4074, 8675"
"WP3611:Photodynamic therapy induced AP 1 survival signaling",0.0217391304347826,19.5412479221203,18.0072959416325,0.00552013972570124,0.0431705559545522,"10018, 3725"
"GO:0061484~hematopoietic stem cell homeostasis",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"8314"
"GO:0001894~tissue homeostasis",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"8314"
"GO:0099149~regulation of postsynaptic neurotransmitter receptor internalization",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"55697"
"GO:0010608~post-transcriptional regulation of gene expression",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"9782"
"GO:0030900~forebrain development",0.021505376344086,19.1647475025963,17.6610017889088,0.00573305064340223,0.0431705559545522,"10818, 546"
"GO:0006622~protein targeting to lysosome",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"4074"
"GO:0061136~regulation of proteasomal protein catabolic process",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"5310"
"GO:0051928~positive regulation of calcium ion transport",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"4638"
"GO:0106222~lncRNA binding",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"1786"
"GO:0005112~Notch binding",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"182"
"GO:0070412~R-SMAD binding",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"3725"
"GO:0004435~phosphatidylinositol phospholipase C activity",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"5335"
"R-HSA-2029485~Role of phospholipids in phagocytosis",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"5335"
"R-HSA-74751~Insulin receptor signalling cascade",0.021505376344086,19.1647475025963,17.6610017889088,0.00573305064340223,0.0431705559545522,"10818, 6464"
"R-HSA-2979096~NOTCH2 Activation and Transmission of Signal to the Nucleus",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"182"
"WP5216:Warburg effect modulated by deubiquitinating enzymes and their substrates",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"3939"
"WP581:EPO receptor signaling",0.0147058823529412,18.7294811189087,17.6610017889088,0.0551410566254104,0.119700144960946,"6464"
"hsa00270_Cysteine_and_methionine_metabolism",0.021505376344086,19.1647475025963,17.6610017889088,0.00573305064340223,0.0431705559545522,"1786, 3939"
"R-HSA-177929~Signaling by EGFR",0.0212765957446809,18.7840466811919,17.3277753400614,0.00594968432177934,0.0431705559545522,"5335, 6464"
"R-HSA-74752~Signaling by Insulin receptor",0.025,19.1019951472788,17.219476744186,0.000703269529354931,0.0151829147707311,"10818, 529, 6464"
"GO:0001782~B cell homeostasis",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"10018"
"GO:0003009~skeletal muscle contraction",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"6198"
"GO:0051894~positive regulation of focal adhesion assembly",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"9448"
"R-HSA-912526~Interleukin receptor SHC signaling",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"6464"
"R-HSA-3000170~Syndecan interactions",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"2335"
"KW-0581~Phagocytosis",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"63916"
"WP3613:Photodynamic therapy induced unfolded protein response",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"10018"
"WP3845:Canonical and non canonical Notch signaling",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"182"
"WP195:IL1 signaling",0.0210526315789474,18.4199999970488,17.0068906115418,0.00617002431335226,0.0431705559545522,"3725, 5335"
"hsa04966_Collecting_duct_acid_secretion",0.0144927536231884,18.0045747416746,17.0068906115418,0.0572014519073774,0.122652364906159,"529"
"WP2380:Brain derived neurotrophic factor BDNF signaling",0.0285714285714286,19.4922878410521,16.7586148361908,1.16389222042669e-05,0.0011916527355279,"10818, 3725, 5335, 6198, 6464"
"WP2272:Pathogenic Escherichia coli infection",0.0208333333333333,18.0708039756643,16.6976744186047,0.00639405422171766,0.0431705559545522,"10094, 203068"
"hsa04066_HIF-1_signaling_pathway",0.0268456375838926,18.9460268086905,16.6976744186047,9.51833808818951e-05,0.00375022520674667,"3939, 5335, 6198, 6921"
"hsa05135_Yersinia_infection",0.0284090909090909,19.3396143462463,16.6371755982474,1.20571127896773e-05,0.0011916527355279,"10094, 2335, 3725, 5335, 63916"
"GO:0090303~positive regulation of wound healing",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"4638"
"GO:0050807~regulation of synapse organization",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"203068"
"GO:0051959~dynein light intermediate chain binding",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"23299"
"GO:0003925~G protein activity",0.0206185567010309,17.7351124414803,16.3995016611296,0.00662175770141307,0.0436648122904895,"10672, 57826"
"R-HSA-5654732~Negative regulation of FGFR3 signaling",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"10818"
"R-HSA-1855204~Synthesis of IP3 and IP4 in the cytosol",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"5335"
"WP2583:T cell receptor and co stimulatory signaling",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"5335"
"WP2643:Nanoparticle mediated activation of receptor signaling",0.0142857142857143,17.3365695344577,16.3995016611296,0.0592574584784283,0.125862202913751,"2335"
"GO:0030155~regulation of cell adhesion",0.0204081632653061,17.4118881523335,16.1117911056712,0.00685311845778106,0.0448154136492239,"4659, 5310"
"GO:0071363~cellular response to growth factor stimulus",0.0204081632653061,17.4118881523335,16.1117911056712,0.00685311845778106,0.0448154136492239,"6198, 6464"
"R-HSA-2029480~Fcgamma receptor (FCGR) dependent phagocytosis",0.0238095238095238,17.7165905468931,16.0181179015684,0.000868088295781477,0.0173178120778684,"10094, 5335, 63916"
"GO:0006906~vesicle fusion",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"8675"
"GO:0014850~response to muscle activity",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"2335"
"GO:0021510~spinal cord development",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"5310"
"GO:0030488~tRNA methylation",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"51504"
"GO:0046875~ephrin receptor binding",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"6464"
"R-HSA-9860927~Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"2335"
"R-HSA-2424491~DAP12 signaling",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"5335"
"R-HSA-186763~Downstream signal transduction",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"5335"
"WP2032:Thyroid stimulating hormone TSH signaling",0.0202020202020202,17.0932327326929,15.8340016038492,0.00708812024683369,0.0461606508636772,"10672, 6198"
"WP241:One carbon metabolism",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"1786"
"WP5351:Kleefstra syndrome",0.0140845070422535,16.7151916402321,15.8340016038492,0.061309085464553,0.127977640651835,"8314"
"hsa05210_Colorectal_cancer",0.0236220472440945,17.4960327484661,15.8340016038492,0.000897732340885993,0.0176853271154541,"10018, 3725, 6198"
"R-HSA-9664422~FCGR3A-mediated phagocytosis",0.02,16.7994323783145,15.5656286953094,0.0073267468751174,0.0469388336389635,"10094, 63916"
"R-HSA-9664407~Parasite infection",0.02,16.7994323783145,15.5656286953094,0.0073267468751174,0.0469388336389635,"10094, 63916"
"R-HSA-9664417~Leishmania phagocytosis",0.02,16.7994323783145,15.5656286953094,0.0073267468751174,0.0469388336389635,"10094, 63916"
"WP4205:MET in type 1 papillary renal cell carcinoma",0.02,16.7994323783145,15.5656286953094,0.0073267468751174,0.0469388336389635,"3725, 5335"
"GO:0046488~phosphatidylinositol metabolic process",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"5335"
"GO:0001569~branching involved in blood vessel morphogenesis",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"10672"
"GO:0034612~response to tumor necrosis factor",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"6198"
"GO:0051721~protein phosphatase 2A binding",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"6198"
"GO:0004712~protein serine/threonine/tyrosine kinase activity",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"6198"
"R-HSA-193648~NRAGE signals death through JNK",0.0198019801980198,16.5070183045317,15.3062015503876,0.00756898219957814,0.0482943965446767,"10018, 10672"
"R-HSA-5654733~Negative regulation of FGFR4 signaling",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"10818"
"R-HSA-77387~Insulin receptor recycling",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"529"
"R-HSA-114452~Activation of BH3-only proteins",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"10018"
"R-HSA-983170~Antigen Presentation: Folding, assembly and peptide loading of class I MHC",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"10484"
"WP129:Matrix metalloproteinases",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"7077"
"WP51:Regulation of actin cytoskeleton",0.0265957446808511,17.7316278882211,15.3062015503876,1.8051499423133e-05,0.00142245815454288,"10672, 2335, 2934, 4638, 4659"
"WP453:Inflammatory response pathway",0.0138888888888889,16.1330074760777,15.3062015503876,0.063356341973228,0.129674798636113,"2335"
"hsa04722_Neurotrophin_signaling_pathway",0.0251572327044025,17.3024955190738,15.3062015503876,0.000133315492766738,0.00500250515715189,"10818, 3725, 5335, 6464"
"hsa05235_PD-L1_expression_and_PD-1_checkpoint_pathway_in_cancer",0.0230769230769231,16.8948155704923,15.3062015503876,0.000990500500966685,0.0183650445826294,"3725, 5335, 6198"
"WP5072:Modulators of TCR signaling and T cell activation",0.0196078431372549,16.2333788422112,15.055280213496,0.00781481012742685,0.0492645630432988,"10672, 5335"
"WP23:B cell receptor signaling",0.0227272727272727,16.5170495890867,14.9734580384226,0.0010555957585727,0.0189047604035293,"3725, 5335, 6464"
"GO:0030833~regulation of actin filament polymerization",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"10094"
"GO:1990000~amyloid fibril formation",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"2934"
"GO:0006346~DNA methylation-dependent constitutive heterochromatin formation",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"1786"
"GO:0045773~positive regulation of axon extension",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"2335"
"GO:0140678~molecular function inhibitor activity",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"7077"
"R-HSA-917977~Transferrin endocytosis and recycling",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"529"
"R-HSA-2029482~Regulation of actin dynamics for phagocytic cup formation",0.0194174757281553,15.9579009129162,14.8124531132783,0.00806421461600528,0.0501278199499169,"10094, 63916"
"R-HSA-6796648~TP53 Regulates Transcription of DNA Repair Genes",0.0194174757281553,15.9579009129162,14.8124531132783,0.00806421461600528,0.0501278199499169,"3725, 6921"
"R-HSA-8874081~MET activates PTK2 signaling",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"2335"
"R-HSA-450282~MAPK targets/ Nuclear events mediated by MAP kinases",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"3725"
"R-HSA-2122948~Activated NOTCH1 Transmits Signal to the Nucleus",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"182"
"R-HSA-456926~Thrombin signalling through proteinase activated receptors (PARs)",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"10672"
"R-HSA-9680350~Signaling by CSF1 (M-CSF) in myeloid cells",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"6464"
"R-HSA-167238~Pausing and recovery of Tat-mediated HIV elongation",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"6921"
"R-HSA-5654726~Negative regulation of FGFR1 signaling",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"10818"
"R-HSA-167243~Tat-mediated HIV elongation arrest and recovery",0.0136986301369863,15.6018108676937,14.8124531132783,0.0653992370934484,0.131298340967229,"6921"
"WP3863:T cell antigen receptor TCR pathway during Staphylococcus aureus infection",0.0194174757281553,15.9579009129162,14.8124531132783,0.00806421461600528,0.0501278199499169,"3725, 5335"
"hsa04658_Th1_and_Th2_cell_differentiation",0.0225563909774436,16.3318356976663,14.8124531132783,0.0010891340573308,0.019286239037678,"182, 3725, 5335"
"GO:0048812~neuron projection morphogenesis",0.0192307692307692,15.6957640666201,14.5773348098929,0.00831717967265211,0.0501278199499169,"4659, 9448"
"R-HSA-1226099~Signaling by FGFR in disease",0.0192307692307692,15.6957640666201,14.5773348098929,0.00831717967265211,0.0501278199499169,"10818, 5335"
"GO:0048565~digestive tract development",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"5310"
"GO:0070050~neuron cellular homeostasis",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"8314"
"GO:0051281~positive regulation of release of sequestered calcium ion into cytosol",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"5335"
"GO:0032206~positive regulation of telomere maintenance",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"546"
"GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"10018"
"GO:0021915~neural tube development",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"5310"
"GO:0032007~negative regulation of TOR signaling",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"54541"
"R-HSA-5654727~Negative regulation of FGFR2 signaling",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"10818"
"R-HSA-2871809~FCERI mediated Ca+2 mobilization",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"5335"
"R-HSA-392518~Signal amplification",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"10672"
"WP2197:Endothelin pathways",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"4638"
"hsa00640_Propanoate_metabolism",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"3939"
"hsa04215_Apoptosis",0.0135135135135135,15.0984312521701,14.3495639534884,0.0674377798957707,0.132521123585704,"10018"
"hsa05206_MicroRNAs_in_cancer",0.0248756218905473,16.2652845082876,14.0854615494364,2.69333818810766e-05,0.00182019707298298,"10018, 1786, 5335, 54541, 6464"
"GO:2001244~positive regulation of intrinsic apoptotic signaling pathway",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"10018"
"GO:0006139~nucleobase-containing compound metabolic process",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"2079"
"GO:0070507~regulation of microtubule cytoskeleton organization",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"23299"
"GO:0035987~endodermal cell differentiation",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"2335"
"GO:0035198~miRNA binding",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"9782"
"R-HSA-167287~HIV elongation arrest and recovery",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"6921"
"R-HSA-5694530~Cargo concentration in the ER",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"10484"
"R-HSA-9725371~Nuclear events stimulated by ALK signaling in cancer",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"1786"
"R-HSA-1592389~Activation of Matrix Metalloproteinases",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"7077"
"R-HSA-167290~Pausing and recovery of HIV elongation",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"6921"
"R-HSA-9861718~Regulation of pyruvate metabolism",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"3939"
"WP422:MAPK cascade",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"3725"
"WP2324:AGE RAGE pathway",0.0186915887850467,14.9589255935712,13.9147286821705,0.0090972790715422,0.0523259555355858,"3725, 6464"
"WP244:Alpha 6 beta 4 signaling",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"6464"
"WP4481:Resistin as a regulator of inflammation",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"5335"
"WP4496:Signal transduction through IL1R",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"3725"
"WP4880:Host pathogen interaction of human coronaviruses interferon induction",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"3725"
"hsa04130_SNARE_interactions_in_vesicular_transport",0.0133333333333333,14.6268561754263,13.9147286821705,0.0694719794323452,0.133521755591922,"8675"
"hsa05231_Choline_metabolism_in_cancer",0.0215827338129496,15.3077996067125,13.9147286821705,0.00130455581483056,0.0212170511016761,"3725, 5335, 6198"
"R-HSA-6802952~Signaling by BRAF and RAF1 fusions",0.0185185185185185,14.7286029817331,13.7070461645262,0.00936432746912155,0.0535736698566649,"10018, 2335"
"hsa04933_AGE-RAGE_signaling_pathway_in_diabetic_complications",0.0212765957446809,14.9945892434291,13.6391895003454,0.00138188978613621,0.0215629534945611,"2335, 3725, 5335"
"GO:0006611~protein export from nucleus",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"5310"
"GO:0033574~response to testosterone",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"6198"
"GO:0001662~behavioral fear response",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"6198"
"GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"54541"
"GO:0031491~nucleosome binding",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"8028"
"WP313:Hepatocyte growth factor receptor signaling",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"3725"
"WP4241:Type 2 papillary renal cell carcinoma",0.0131578947368421,14.1842431688566,13.5054719562243,0.0715018447369516,0.136095298678063,"6921"
"hsa04371_Apelin_signaling_pathway",0.0224719101123595,14.8584995693573,13.2139869499749,0.000234546212048772,0.00803575717801881,"10672, 182, 4638, 6198"
"GO:0007160~cell-matrix adhesion",0.0206896551724138,14.4054256931475,13.1196013289037,0.0015450821730237,0.0227574720064051,"10018, 2335, 5310"
"GO:0043408~regulation of MAPK cascade",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"9448"
"GO:1990090~cellular response to nerve growth factor stimulus",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"10094"
"GO:0045931~positive regulation of mitotic cell cycle",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"6198"
"GO:0010634~positive regulation of epithelial cell migration",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"5335"
"GO:0045787~positive regulation of cell cycle",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"10018"
"R-HSA-202433~Generation of second messenger molecules",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"5335"
"R-HSA-5654738~Signaling by FGFR2",0.018018018018018,14.0787927037695,13.1196013289037,0.0101862980293598,0.0571302693746302,"10818, 5335"
"R-HSA-9833109~Evasion by RSV of host interferon responses",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"6921"
"R-HSA-9645723~Diseases of programmed cell death",0.0206896551724138,14.4054256931475,13.1196013289037,0.0015450821730237,0.0227574720064051,"10018, 1786, 3725"
"WP400:p38 MAPK signaling",0.012987012987013,13.7680082201071,13.1196013289037,0.0735273848250401,0.138115802722602,"6464"
"WP5130:Th17 cell differentiation pathway",0.018018018018018,14.0787927037695,13.1196013289037,0.0101862980293598,0.0571302693746302,"3725, 5335"
"hsa05211_Renal_cell_carcinoma",0.018018018018018,14.0787927037695,13.1196013289037,0.0101862980293598,0.0571302693746302,"3725, 6921"
"GO:1903955~positive regulation of protein targeting to mitochondrion",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"8314"
"GO:0007017~microtubule-based process",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"203068"
"GO:0030330~DNA damage response, signal transduction by p53 class mediator",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"546"
"GO:0072593~reactive oxygen species metabolic process",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"54541"
"GO:2001237~negative regulation of extrinsic apoptotic signaling pathway",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"6198"
"GO:0005154~epidermal growth factor receptor binding",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"6464"
"GO:0051059~NF-kappaB binding",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"25855"
"R-HSA-5663213~RHO GTPases Activate WASPs and WAVEs",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"10094"
"R-HSA-6802948~Signaling by high-kinase activity BRAF mutants",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"2335"
"R-HSA-1266695~Interleukin-7 signaling",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"54014"
"R-HSA-432720~Lysosome Vesicle Biogenesis",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"4074"
"WP3850:Factors and pathways affecting insulin like growth factor IGF1 Akt signaling",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"6198"
"WP2572:Primary focal segmental glomerulosclerosis FSGS ",0.0176991150442478,13.6768631332993,12.7551679586563,0.0107514765336178,0.0581360021617923,"182, 5335"
"WP4877:Host pathogen interaction of human coronaviruses MAPK signaling",0.0128205128205128,13.3758094311632,12.7551679586563,0.0755486086937627,0.139583361431852,"3725"
"WP5380:5q35 copy number variation",0.0201342281879195,13.8611275620613,12.6381480691274,0.0017198926095517,0.024641370478668,"10818, 3725, 5335"
"WP4216:Chromosomal and microsatellite instability in colorectal cancer ",0.0175438596491228,13.4844523021221,12.5804396304556,0.011039178578842,0.0589754082720508,"10018, 3725"
"WP710:DNA damage response only ATM dependent ",0.02,13.7314483014006,12.5232558139535,0.00176544520474806,0.0250661409250715,"10018, 3725, 6464"
"GO:0043029~T cell homeostasis",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"10018"
"GO:0002218~activation of innate immune response",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"9782"
"GO:0003180~aortic valve morphogenesis",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"182"
"GO:0005484~SNAP receptor activity",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"8675"
"GO:0140416~transcription regulator inhibitor activity",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"5310"
"R-HSA-2129379~Molecules associated with elastic fibres",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"2335"
"R-HSA-111465~Apoptotic cleavage of cellular proteins",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"2934"
"R-HSA-1980145~Signaling by NOTCH2",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"182"
"WP4331:Neovascularization processes",0.0126582278481013,12.995220629214,12.4104336895035,0.0775655253220126,0.141813535855559,"182"
"hsa05224_Breast_cancer",0.0213903743315508,13.9267403856101,12.4104336895035,0.000297999149963747,0.00978430542380969,"182, 3725, 6198, 6464"
"GO:0018105~peptidyl-serine phosphorylation",0.0170940170940171,12.9282866485166,12.0838433292534,0.0119225506145051,0.0628335834008719,"5310, 6198"
"GO:0051225~spindle assembly",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"203068"
"GO:0042267~natural killer cell mediated cytotoxicity",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"203068"
"GO:0031297~replication fork processing",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"546"
"GO:0042277~peptide binding",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"6198"
"R-HSA-1222556~ROS and RNS production in phagocytes",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"529"
"R-HSA-9675126~Diseases of mitotic cell cycle",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"546"
"R-HSA-187037~Signaling by NTRK1 (TRKA)",0.0194805194805195,13.2254421058237,12.0838433292534,0.0019551905106915,0.0263365832893146,"10818, 5335, 6464"
"R-HSA-9607240~FLT3 Signaling",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"10018"
"WP3614:Photodynamic therapy induced HIF 1 survival signaling",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"3939"
"WP2036:TNF related weak inducer of apoptosis TWEAK signaling",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"3725"
"WP5215:Targeted agents in triple negative breast cancer",0.0125,12.6455291667949,12.0838433292534,0.0795781436704571,0.143824718376881,"6198"
"hsa05214_Glioma",0.0170940170940171,12.9282866485166,12.0838433292534,0.0119225506145051,0.0628335834008719,"5335, 6464"
"GO:0071346~cellular response to type II interferon",0.0169491525423729,12.7562567626712,11.9269102990033,0.0122237120771416,0.0628335834008719,"2934, 6198"
"R-HSA-5687128~MAPK6/MAPK4 signaling",0.0169491525423729,12.7562567626712,11.9269102990033,0.0122237120771416,0.0628335834008719,"3725, 989"
"R-HSA-204998~Cell death signalling via NRAGE, NRIF and NADE",0.0169491525423729,12.7562567626712,11.9269102990033,0.0122237120771416,0.0628335834008719,"10018, 10672"
"hsa04810_Regulation_of_actin_cytoskeleton",0.0223048327137546,13.9721840787258,11.8755012028869,1.04542352636914e-05,0.0011916527355279,"10094, 10672, 2335, 2934, 4638, 4659"
"GO:0006953~acute-phase response",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"2335"
"GO:0007281~germ cell development",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"6198"
"GO:0007616~long-term memory",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"6198"
"GO:0043542~endothelial cell migration",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"2335"
"GO:0043536~positive regulation of blood vessel endothelial cell migration",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"5335"
"GO:0030041~actin filament polymerization",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"2934"
"R-HSA-9840310~Glycosphingolipid catabolism",0.0123456790123457,12.3137962827671,11.7740011926058,0.0815864726815784,0.145948105500758,"4074"
"WP5381:Smith Magenis and Potocki Lupski syndrome copy number variation",0.0205128205128205,13.1806557517283,11.7740011926058,0.000364006716937965,0.0112485212920438,"10018, 3725, 3939, 4659"
"WP437:EGF EGFR signaling",0.0202020202020202,12.9271948073407,11.5518502267076,0.000391261329277819,0.0116344878290914,"3725, 5335, 6198, 6464"
"WP306:Focal adhesion",0.0210970464135021,13.2238697154662,11.537337852051,6.97331074028398e-05,0.00319648469967496,"2335, 3725, 4638, 4659, 6464"
"GO:0001974~blood vessel remodeling",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"182"
"GO:0009725~response to hormone",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"7077"
"GO:0048536~spleen development",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"10018"
"GO:0005261~monoatomic cation channel activity",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"5310"
"R-HSA-5674135~MAP2K and MAPK activation",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"2335"
"R-HSA-9664323~FCGR3A-mediated IL10 synthesis",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"5335"
"WP2516:ATM signaling",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"3725"
"WP4564:Neural crest cell migration during development",0.0121951219512195,11.9976389381882,11.4796511627907,0.0835905212797059,0.148187470795069,"3725"
"WP481:Insulin signaling",0.0201005025125628,12.8437195815391,11.4796511627907,0.000400662031235266,0.0116933955782737,"3725, 6198, 6464, 9448"
"hsa05205_Proteoglycans_in_cancer",0.0209205020920502,13.0876689545424,11.4225384704385,7.31107349376077e-05,0.0032006255072686,"10818, 2335, 4659, 5335, 6198"
"WP4239:Epithelial to mesenchymal transition in colorectal cancer",0.02,12.7613075813202,11.4083489816554,0.000410223286932265,0.0117547618219136,"182, 2335, 5310, 6464"
"hsa04510_Focal_adhesion",0.020746887966805,12.9542190651166,11.3100011456066,7.66132561369775e-05,0.00326331058572639,"2335, 3725, 4638, 4659, 6464"
"WP4549:Fragile X syndrome",0.0185185185185185,12.3355790444723,11.291460160122,0.0023717518466588,0.0281043677468742,"5335, 6198, 6464"
"GO:0043588~skin development",0.0120481927710843,11.6972850855841,11.1996596710153,0.0855902983710515,0.151052978984073,"5310"
"R-HSA-180585~Vif-mediated degradation of APOBEC3G",0.0120481927710843,11.6972850855841,11.1996596710153,0.0855902983710515,0.151052978984073,"6921"
"R-HSA-9658195~Leishmania infection",0.0196078431372549,12.4418952076459,11.1317829457364,0.000450105628552848,0.0121440580717323,"10094, 3725, 5335, 63916"
"R-HSA-9824443~Parasitic Infection Pathways",0.0196078431372549,12.4418952076459,11.1317829457364,0.000450105628552848,0.0121440580717323,"10094, 3725, 5335, 63916"
"hsa05131_Shigellosis",0.0210526315789474,13.0334186470944,11.1093398349587,1.52657138196038e-05,0.00137855290125614,"10094, 3725, 5335, 6198, 63916, 989"
"GO:0007405~neuroblast proliferation",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"10818"
"R-HSA-6802957~Oncogenic MAPK signaling",0.016,11.6655561042856,10.9330011074197,0.0144241383126713,0.0680123336499054,"10018, 2335"
"R-HSA-8875878~MET promotes cell motility",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"2335"
"R-HSA-3928662~EPHB-mediated forward signaling",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"10094"
"R-HSA-165159~MTOR signalling",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"6198"
"R-HSA-109704~PI3K Cascade",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"10818"
"R-HSA-9696273~RND1 GTPase cycle",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"10818"
"R-HSA-6782315~tRNA modification in the nucleus and cytosol",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"51504"
"WP5220:Metabolic reprogramming in pancreatic cancer",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"3939"
"WP4290:Metabolic reprogramming in colon cancer",0.0119047619047619,11.4115827618764,10.9330011074197,0.0875858128437496,0.1526938507099,"3939"
"hsa04611_Platelet_activation",0.0180722891566265,11.9322224212047,10.9330011074197,0.00259910381076991,0.0301963438232608,"10672, 4638, 4659"
"GO:0031490~chromatin DNA binding",0.0158730158730159,11.5245064711118,10.8043775649795,0.0147514892451891,0.0680123336499054,"546, 8314"
"R-HSA-190236~Signaling by FGFR",0.0158730158730159,11.5245064711118,10.8043775649795,0.0147514892451891,0.0680123336499054,"10818, 5335"
"WP4018:Clear cell renal cell carcinoma pathways",0.0158730158730159,11.5245064711118,10.8043775649795,0.0147514892451891,0.0680123336499054,"3939, 8314"
"WP254:Apoptosis",0.0158730158730159,11.5245064711118,10.8043775649795,0.0147514892451891,0.0680123336499054,"10018, 3725"
"WP2571:Polycystic kidney disease pathway",0.0158730158730159,11.5245064711118,10.8043775649795,0.0147514892451891,0.0680123336499054,"3725, 5310"
"GO:0045815~transcription initiation-coupled chromatin remodeling",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"51504"
"GO:0030010~establishment of cell polarity",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"5310"
"GO:0048870~cell motility",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"63916"
"GO:0019843~rRNA binding",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"51335"
"R-HSA-9696270~RND2 GTPase cycle",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"10818"
"R-HSA-1489509~DAG and IP3 signaling",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"5335"
"R-HSA-167200~Formation of HIV-1 elongation complex containing HIV-1 Tat",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"6921"
"R-HSA-167169~HIV Transcription Elongation",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"6921"
"R-HSA-167246~Tat-mediated elongation of the HIV-1 transcript",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"6921"
"R-HSA-9656223~Signaling by RAF1 mutants",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"2335"
"WP314:Fas ligand pathway and stress induction of heat shock proteins",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"3725"
"WP5198:Inflammatory bowel disease signaling",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"3725"
"WP4565:Neural crest cell migration in cancer",0.0117647058823529,11.1394826360232,10.6787452677123,0.089577073567889,0.153449421677166,"3725"
"WP3888:VEGFA VEGFR2 signaling",0.021551724137931,13.8659470052282,10.6539685965575,2.22894281843409e-08,3.51281388185212e-05,"10818, 182, 2335, 3725, 3939, 529, 5335, 6198, 6464, 6921"
"R-HSA-8878159~Transcriptional regulation by RUNX3",0.015625,11.2523600181119,10.5560010692328,0.0154157949769986,0.0690207184197438,"10018, 182"
"GO:0046627~negative regulation of insulin receptor signaling pathway",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"6198"
"GO:0150052~regulation of postsynapse assembly",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"10672"
"R-HSA-9634597~GPER1 signaling",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"2335"
"R-HSA-1566948~Elastic fibre formation",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"2335"
"R-HSA-451927~Interleukin-2 family signaling",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"6464"
"R-HSA-2565942~Regulation of PLK1 Activity at G2/M Transition",0.0155038759689922,11.1210312596516,10.4360465116279,0.0157527201589266,0.0701307541538652,"203068, 4659"
"R-HSA-373752~Netrin-1 signaling",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"5335"
"WP3915:Angiopoietin like protein 8 regulatory pathway",0.0174418604651163,11.3740744041459,10.4360465116279,0.00296468920143413,0.0332208624011421,"6198, 6464, 9448"
"WP366:TGF beta signaling pathway",0.0174418604651163,11.3740744041459,10.4360465116279,0.00296468920143413,0.0332208624011421,"2335, 3725, 6464"
"WP2332:IL11 signaling",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"6198"
"WP5098:T cell activation SARS CoV 2",0.0155038759689922,11.1210312596516,10.4360465116279,0.0157527201589266,0.0701307541538652,"3725, 5335"
"WP4936:Perturbations to host cell autophagy induced by SARS CoV 2 proteins",0.0116279069767442,10.8815450727364,10.4360465116279,0.0915640893955505,0.155000005249611,"6198"
"R-HSA-166520~Signaling by NTRKs",0.0173410404624277,11.2860562840264,10.3575799965029,0.00302853421691886,0.0332208624011421,"10818, 5335, 6464"
"GO:0050804~modulation of chemical synaptic transmission",0.0153846153846154,10.9941345670481,10.3187875620591,0.0160928072177588,0.0714429976765857,"5335, 6198"
"GO:0001701~in utero embryonic development",0.0191570881226054,11.7556043361604,10.2956512670769,0.000119223860169602,0.00458284886895837,"10018, 10672, 5310, 5335, 8314"
"GO:0000278~mitotic cell cycle",0.0172413793103448,11.1993811401895,10.2802846233947,0.00309322176120469,0.0332208624011421,"203068, 4659, 8314"
"hsa04270_Vascular_smooth_muscle_contraction",0.0172413793103448,11.1993811401895,10.2802846233947,0.00309322176120469,0.0332208624011421,"10672, 4638, 4659"
"GO:0006661~phosphatidylinositol biosynthetic process",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"55697"
"GO:0008333~endosome to lysosome transport",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"4074"
"GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"3939"
"R-HSA-445355~Smooth Muscle Contraction",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"4638"
"R-HSA-167152~Formation of HIV elongation complex in the absence of HIV Tat",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"6921"
"WP2873:Aryl hydrocarbon receptor pathway",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"3725"
"WP1772:Apoptosis modulation and signaling",0.0152671755725191,10.8687503085281,10.2041343669251,0.0164360414613223,0.0722909802555966,"10018, 3725"
"WP268:Notch signaling",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"182"
"WP534:Glycolysis and gluconeogenesis",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"3939"
"WP5488:Pathways into methionine and folate cycles",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"1786"
"WP5493:Effect of dasatinib on the BCR ABL signaling pathway",0.0114942528735632,10.633920932458,10.2041343669251,0.0935468691608409,0.156175705293946,"6464"
"GO:0008360~regulation of cell shape",0.0170454545454545,11.0312540392345,10.1291039671683,0.00322513898270108,0.0340420305072788,"10672, 2335, 54014"
"R-HSA-202733~Cell surface interactions at the vascular wall",0.0170454545454545,11.0312540392345,10.1291039671683,0.00322513898270108,0.0340420305072788,"2335, 5335, 6464"
"GO:0005198~structural molecule activity",0.018018018018018,11.1828547591551,10.036853475664,0.00066442912176802,0.0147484548719211,"182, 203068, 9782, 989"
"GO:0071364~cellular response to epidermal growth factor stimulus",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"5335"
"R-HSA-9830369~Kidney development",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"182"
"R-HSA-112399~IRS-mediated signalling",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"10818"
"WP5411:Phosphatidyl inositol phosphate pathway",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"5335"
"WP4566:Translation inhibitors in chronically activated PDGFRA cells",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"6198"
"WP4861:Endoplasmic reticulum stress response in coronavirus infection",0.0113636363636364,10.3972558536609,9.98230535894843,0.0955254216799312,0.158138723285264,"4659"
"WP4746:Thyroid hormones production and peripheral downstream signaling effects",0.0149253731343284,10.5087714539025,9.87496874218555,0.0174844810735931,0.0728982597142398,"10818, 6198"
"GO:1902459~positive regulation of stem cell population maintenance",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"25855"
"GO:0034097~response to cytokine",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"7077"
"GO:0031667~response to nutrient levels",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"6198"
"GO:0019905~syntaxin binding",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"8675"
"R-HSA-6802949~Signaling by RAS mutants",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"2335"
"R-HSA-6802955~Paradoxical activation of RAF signaling by kinase inactive BRAF",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"2335"
"R-HSA-6811438~Intra-Golgi traffic",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"8675"
"R-HSA-6802946~Signaling by moderate kinase activity BRAF mutants",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"2335"
"R-HSA-9649948~Signaling downstream of RAS mutants",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"2335"
"R-HSA-9839373~Signaling by TGFBR3",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"7077"
"WP28:Selenium metabolism and selenoproteins",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"3725"
"WP4534:Mechanoregulation and pathology of YAP TAZ via Hippo and non Hippo mechanisms",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"9448"
"hsa00620_Pyruvate_metabolism",0.0112359550561798,10.1703347341123,9.76991588322613,0.0974997557510903,0.158863906406898,"3939"
"hsa05323_Rheumatoid_arthritis",0.0148148148148148,10.3958791999586,9.76991588322613,0.0178401580600441,0.0741849316692073,"3725, 529"
"GO:0030336~negative regulation of cell migration",0.016304347826087,10.3989282111967,9.56637596899225,0.00378722165108573,0.0376759290785283,"182, 25855, 57826"
"GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"10018"
"GO:0021762~substantia nigra development",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"3939"
"GO:0007098~centrosome cycle",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"4659"
"GO:0045747~positive regulation of Notch signaling pathway",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"182"
"GO:0051209~release of sequestered calcium ion into cytosol",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"5335"
"GO:0006096~glycolytic process",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"3939"
"GO:0034446~substrate adhesion-dependent cell spreading",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"2335"
"GO:0061749~forked DNA-dependent helicase activity",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"546"
"GO:0001784~phosphotyrosine residue binding",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"6464"
"GO:0004857~enzyme inhibitor activity",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"4659"
"R-HSA-9012852~Signaling by NOTCH3",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"182"
"WP5347:IL26 signaling",0.0111111111111111,9.95050888623491,9.56637596899225,0.0994698801547208,0.158863906406898,"3725"
"GO:0034976~response to endoplasmic reticulum stress",0.0144927536231884,10.0623495479157,9.46775353632222,0.018925577904243,0.076378739408631,"10018, 3725"
"R-HSA-4420097~VEGFA-VEGFR2 Pathway",0.0144927536231884,10.0623495479157,9.46775353632222,0.018925577904243,0.076378739408631,"5335, 63916"
"GO:0048538~thymus development",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"10018"
"GO:0006367~transcription initiation at RNA polymerase II promoter",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"6921"
"GO:0036121~double-stranded DNA helicase activity",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"546"
"GO:0009378~four-way junction helicase activity",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"546"
"GO:1990518~single-stranded 3'-5' DNA helicase activity",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"546"
"R-HSA-70268~Pyruvate metabolism",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"3939"
"R-HSA-512988~Interleukin-3, Interleukin-5 and GM-CSF signaling",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"6464"
"WP3646:Hepatitis C and hepatocellular carcinoma",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"3725"
"WP4971:Phosphoinositides metabolism",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"5335"
"WP5475:Hallmark of cancer sustaining proliferative signaling",0.0143884892086331,9.95744777619902,9.37114380635975,0.0192934662466857,0.076378739408631,"3725, 6464"
"hsa05030_Cocaine_addiction",0.010989010989011,9.74397607489359,9.37114380635975,0.101435803653393,0.158863906406898,"3725"
"R-HSA-193704~p75 NTR receptor-mediated signalling",0.0142857142857143,9.85458605382099,9.27648578811369,0.0196643716164146,0.0769566746278055,"10018, 10672"
"hsa04072_Phospholipase_D_signaling_pathway",0.0158730158730159,10.0413550115209,9.24535664117372,0.00416703780390027,0.0376759290785283,"10672, 5335, 6464"
"GO:0045599~negative regulation of fat cell differentiation",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"182"
"GO:0001222~transcription corepressor binding",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"6921"
"R-HSA-381038~XBP1(S) activates chaperone genes",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"6464"
"R-HSA-1483249~Inositol phosphate metabolism",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"5335"
"R-HSA-2428924~IGF1R signaling cascade",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"10818"
"R-HSA-2428928~IRS-related events triggered by IGF1R",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"10818"
"WP5373:Osteoarthritic chondrocyte hypertrophy",0.0108695652173913,9.54523973577067,9.18372093023256,0.103397534991883,0.160230595031669,"3725"
"hsa05132_Salmonella_infection",0.0173010380622837,10.400662291075,9.14713240063004,0.00020697025565998,0.00731585660849605,"10094, 203068, 3725, 4074, 63916"
"R-HSA-9679191~Potential therapeutics for SARS",0.0140845070422535,9.6548729587809,9.09279300023026,0.0204151765470038,0.079242118645001,"203068, 25855"
"hsa05130_Pathogenic_Escherichia_coli_infection",0.0165289256198347,10.0455857506474,9.04800091648528,0.000978092175709459,0.0183508722490251,"10094, 10672, 203068, 3725"
"GO:0048146~positive regulation of fibroblast proliferation",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"2335"
"GO:0006890~retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"23299"
"GO:0009968~negative regulation of signal transduction",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"54541"
"R-HSA-2172127~DAP12 interactions",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"5335"
"R-HSA-75153~Apoptotic execution phase",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"2934"
"R-HSA-2404192~Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"10818"
"WP3286:Copper homeostasis",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"3725"
"WP4539:Synaptic signaling associated with autism spectrum disorder",0.010752688172043,9.35415812121213,9.00364797081623,0.105355082897206,0.161831979187132,"6198"
"hsa04921_Oxytocin_signaling_pathway",0.0154639175257732,9.7041858085783,8.94518272425249,0.00456927468840557,0.0393506934914054,"3725, 4638, 4659"
"GO:0007173~epidermal growth factor receptor signaling pathway",0.0138888888888889,9.46069370044452,8.91623391284714,0.0211778793652701,0.079242118645001,"5335, 6464"
"WP4262:Breast cancer pathway",0.0153846153846154,9.64491167311275,8.88747186796699,0.00465244657537205,0.0398492163194911,"3725, 6198, 6464"
"GO:0031334~positive regulation of protein-containing complex assembly",0.0106382978723404,9.17296636497334,8.83050089445438,0.107308456078654,0.163874153856549,"10018"
"R-HSA-5620920~Cargo trafficking to the periciliary membrane",0.0106382978723404,9.17296636497334,8.83050089445438,0.107308456078654,0.163874153856549,"5310"
"R-HSA-381070~IRE1alpha activates chaperones",0.0106382978723404,9.17296636497334,8.83050089445438,0.107308456078654,0.163874153856549,"6464"
"KW-0914~Notch signaling pathway",0.0106382978723404,9.17296636497334,8.83050089445438,0.107308456078654,0.163874153856549,"182"
"WP4747:Netrin UNC5B signaling",0.0106382978723404,9.17296636497334,8.83050089445438,0.107308456078654,0.163874153856549,"3725"
"hsa04145_Phagosome",0.0152284263959391,9.51775637143348,8.77425566582729,0.004821538794652,0.0408534684966213,"203068, 4074, 529"
"hsa04150_mTOR_signaling_pathway",0.0152284263959391,9.51775637143348,8.77425566582729,0.004821538794652,0.0408534684966213,"529, 54541, 6198"
"R-HSA-1234176~Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",0.0105263157894737,8.99479188162851,8.66388767003071,0.109257663227825,0.166528121128677,"6921"
"WP2864:Apoptosis related network due to altered Notch3 in ovarian cancer",0.0105263157894737,8.99479188162851,8.66388767003071,0.109257663227825,0.166528121128677,"6198"
"WP5366:NF1 copy number variation syndrome ",0.0136054421768707,9.18962085907602,8.66388767003071,0.0223439959881134,0.0813827835766491,"1786, 203068"
"hsa05170_Human_immunodeficiency_virus_1_infection",0.0158730158730159,9.56273169005921,8.62321214106344,0.00116867107002324,0.0202398418280948,"3725, 5335, 6198, 6921"
"GO:0048661~positive regulation of smooth muscle cell proliferation",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"6198"
"GO:0031648~protein destabilization",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"2934"
"GO:2000045~regulation of G1/S transition of mitotic cell cycle",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"5310"
"GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"10672"
"R-HSA-194138~Signaling by VEGF",0.0134228187919463,9.01482431944009,8.50344530577089,0.0231359524087196,0.0813827835766491,"5335, 63916"
"R-HSA-8848021~Signaling by PTK6",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"63916"
"R-HSA-9006927~Signaling by Non-Receptor Tyrosine Kinases",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"63916"
"R-HSA-1655829~Regulation of cholesterol biosynthesis by SREBP (SREBF)",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"10484"
"WP4321:Thermogenesis",0.0134228187919463,9.01482431944009,8.50344530577089,0.0231359524087196,0.0813827835766491,"10818, 6198"
"WP560:TGF beta receptor signaling",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"3725"
"WP585:Interferon type I signaling",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"6198"
"WP61:Notch signaling",0.0104166666666667,8.82405493798931,8.50344530577089,0.111202713018664,0.167708589203267,"182"
"hsa04659_Th17_cell_differentiation",0.0133333333333333,8.93001000650517,8.42543204608492,0.0235362525918816,0.0813827835766491,"3725, 5335"
"GO:1904263~positive regulation of TORC1 signaling",0.0103092783505155,8.6600094953751,8.34883720930233,0.113143614107496,0.169661594513238,"6198"
"R-HSA-109606~Intrinsic Pathway for Apoptosis",0.0103092783505155,8.6600094953751,8.34883720930233,0.113143614107496,0.169661594513238,"10018"
"R-HSA-9662361~Sensory processing of sound by outer hair cells of the cochlea",0.0103092783505155,8.6600094953751,8.34883720930233,0.113143614107496,0.169661594513238,"2934"
"R-HSA-9639288~Amino acids regulate mTORC1",0.0103092783505155,8.6600094953751,8.34883720930233,0.113143614107496,0.169661594513238,"529"
"KW-0375~Hydrogen ion transport",0.0103092783505155,8.6600094953751,8.34883720930233,0.113143614107496,0.169661594513238,"529"
"hsa04022_cGMP-PKG_signaling_pathway",0.0145631067961165,8.98702715584726,8.29854300924629,0.00562836988782621,0.0431705559545522,"10672, 4638, 4659"
"GO:0002020~protease binding",0.0131578947368421,8.76519298846558,8.27362245966897,0.0243454279639806,0.0830484728814578,"2335, 7077"
"GO:0005200~structural constituent of cytoskeleton",0.0131578947368421,8.76519298846558,8.27362245966897,0.0243454279639806,0.0830484728814578,"10094, 203068"
"GO:0016241~regulation of macroautophagy",0.0102040816326531,8.5020988342573,8.19975083056478,0.115080375133061,0.171911536691663,"529"
"R-HSA-6811436~COPI-independent Golgi-to-ER retrograde traffic",0.0102040816326531,8.5020988342573,8.19975083056478,0.115080375133061,0.171911536691663,"23299"
"WP2374:Oncostatin M signaling",0.0102040816326531,8.5020988342573,8.19975083056478,0.115080375133061,0.171911536691663,"6464"
"WP4754:IL18 signaling",0.0102040816326531,8.5020988342573,8.19975083056478,0.115080375133061,0.171911536691663,"6198"
"hsa05225_Hepatocellular_carcinoma",0.0143540669856459,8.82301210149227,8.15123159488097,0.00591424136997885,0.0431705559545522,"5335, 6198, 6464"
"hsa04530_Tight_junction",0.0142857142857143,8.76987004420004,8.10328317373461,0.00601143560599011,0.0431705559545522,"10094, 3725, 57826"
"GO:0009612~response to mechanical stimulus",0.0101010101010101,8.35019488527727,8.05589555283558,0.117013004716548,0.17381008052147,"6198"
"GO:0071230~cellular response to amino acid stimulus",0.0101010101010101,8.35019488527727,8.05589555283558,0.117013004716548,0.17381008052147,"1786"
"WP5265:Neurogenesis regulation in the olfactory epithelium",0.0101010101010101,8.35019488527727,8.05589555283558,0.117013004716548,0.17381008052147,"182"
"WP4917:Proximal tubule transport",0.0101010101010101,8.35019488527727,8.05589555283558,0.117013004716548,0.17381008052147,"529"
"R-HSA-5663202~Diseases of signal transduction by growth factor receptors and second messengers",0.0162271805273834,9.77345266603492,8.02071696963542,5.60469320932928e-06,0.000802999681627541,"10018, 10818, 1786, 182, 2335, 3725, 5335, 6464"
"GO:0007259~cell surface receptor signaling pathway via JAK-STAT",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"5310"
"R-HSA-917937~Iron uptake and transport",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"529"
"R-HSA-2894858~Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"R-HSA-186797~Signaling by PDGF",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"5335"
"R-HSA-1236394~Signaling by ERBB4",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"6464"
"R-HSA-75955~RNA Polymerase II Transcription Elongation",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"6921"
"R-HSA-2644606~Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"R-HSA-2644602~Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"R-HSA-2644603~Signaling by NOTCH1 in Cancer",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"R-HSA-112382~Formation of RNA Pol II elongation complex ",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"6921"
"R-HSA-1660662~Glycosphingolipid metabolism",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"4074"
"R-HSA-2894862~Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"WP5236:Markers of kidney cell lineage",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"182"
"WP4816:TGF beta receptor signaling in skeletal dysplasias",0.01,8.20289108660482,7.91700080192462,0.118941511461631,0.174211730542315,"3725"
"GO:0042475~odontogenesis of dentin-containing tooth",0.0099009900990099,8.06006030118532,7.78281434765471,0.120865903954502,0.176048673412473,"10018"
"KW-0341~Growth regulation",0.0099009900990099,8.06006030118532,7.78281434765471,0.120865903954502,0.176048673412473,"6464"
"hsa04668_TNF_signaling_pathway",0.0125,8.16368138349016,7.71741254641391,0.0276944614791244,0.0876003871619762,"182, 3725"
"GO:0045665~negative regulation of neuron differentiation",0.00980392156862745,7.92427587590133,7.6531007751938,0.122786190763907,0.178023032791092,"182"
"GO:0001822~kidney development",0.0124223602484472,8.09315920236439,7.6531007751938,0.028125505015203,0.0876003871619762,"10018, 5310"
"GO:0007266~Rho protein signal transduction",0.00980392156862745,7.92427587590133,7.6531007751938,0.122786190763907,0.178023032791092,"10672"
"R-HSA-2454202~Fc epsilon receptor (FCERI) signaling",0.0124223602484472,8.09315920236439,7.6531007751938,0.028125505015203,0.0876003871619762,"3725, 5335"
"WP5470:Effect of omega 3 PUFA on Huntington 39 s disease pathways",0.0124223602484472,8.09315920236439,7.6531007751938,0.028125505015203,0.0876003871619762,"10018, 6198"
"WP5222:2q13 copy number variation syndrome",0.00980392156862745,7.92427587590133,7.6531007751938,0.122786190763907,0.178023032791092,"10018"
"hsa04370_VEGF_signaling_pathway",0.00980392156862745,7.92427587590133,7.6531007751938,0.122786190763907,0.178023032791092,"5335"
"hsa04730_Long-term_depression",0.00980392156862745,7.92427587590133,7.6531007751938,0.122786190763907,0.178023032791092,"10672"
"GO:1902895~positive regulation of miRNA transcription",0.00970873786407767,7.79187639530563,7.527640106748,0.124702380441182,0.180303625298443,"3725"
"R-HSA-6790901~rRNA modification in the nucleus and cytosol",0.00970873786407767,7.79187639530563,7.527640106748,0.124702380441182,0.180303625298443,"51504"
"WP2006:miR targeted genes in squamous cell",0.0122699386503067,7.95752828448494,7.527640106748,0.0289957211881611,0.089249225759137,"10484, 546"
"hsa04660_T_cell_receptor_signaling_pathway",0.0122699386503067,7.95752828448494,7.527640106748,0.0289957211881611,0.089249225759137,"3725, 5335"
"hsa04935_Growth_hormone_synthesis,_secretion_and_action",0.0122699386503067,7.95752828448494,7.527640106748,0.0289957211881611,0.089249225759137,"5335, 6464"
"R-HSA-1234174~Cellular response to hypoxia",0.00961538461538462,7.66384392335551,7.40622655663916,0.126614481520283,0.182232349658417,"6921"
"R-HSA-8943724~Regulation of PTEN gene transcription",0.00961538461538462,7.66384392335551,7.40622655663916,0.126614481520283,0.182232349658417,"3725"
"WP5362:TAR syndrome",0.00961538461538462,7.66384392335551,7.40622655663916,0.126614481520283,0.182232349658417,"54541"
"hsa04213_Longevity_regulating_pathway",0.00961538461538462,7.66384392335551,7.40622655663916,0.126614481520283,0.182232349658417,"6198"
"hsa04330_Notch_signaling_pathway",0.00961538461538462,7.66384392335551,7.40622655663916,0.126614481520283,0.182232349658417,"182"
"R-HSA-5683057~MAPK family signaling cascades",0.0142045454545455,8.25535877248219,7.31187972152274,0.000577881175038365,0.0134977126801992,"10818, 2335, 3725, 6464, 989"
"GO:0032456~endocytic recycling",0.00952380952380952,7.53997963688958,7.28866740494647,0.128522502517826,0.184305244738939,"8675"
"GO:0010595~positive regulation of endothelial cell migration",0.00952380952380952,7.53997963688958,7.28866740494647,0.128522502517826,0.184305244738939,"54453"
"GO:0009749~response to glucose",0.00952380952380952,7.53997963688958,7.28866740494647,0.128522502517826,0.184305244738939,"6198"
"R-HSA-2559580~Oxidative Stress Induced Senescence",0.0119760479041916,7.69947248699449,7.28866740494647,0.0307682999069081,0.0911481967167051,"3725, 9448"
"R-HSA-450294~MAP kinase activation",0.00952380952380952,7.53997963688958,7.28866740494647,0.128522502517826,0.184305244738939,"3725"
"WP2003:miR targeted genes in leukocytes",0.0119047619047619,7.63756335280904,7.23127632301776,0.0312180651517586,0.0923070744449748,"10672, 9782"
"WP5115:Network map of SARS CoV 2 signaling",0.0136518771331058,7.97790435856469,7.23127632301776,0.00222596329415716,0.0271947143534239,"2335, 2934, 3725, 54541"
"WP5434:Cancer pathways",0.0147058823529412,8.75734468396445,7.21706949330653,1.2097997315004e-05,0.0011916527355279,"10018, 10672, 182, 2335, 3725, 5335, 6198, 6921"
"GO:0030097~hemopoiesis",0.00943396226415094,7.42009494417303,7.17478197674419,0.130426451933116,0.186357287621569,"182"
"GO:0043525~positive regulation of neuron apoptotic process",0.00943396226415094,7.42009494417303,7.17478197674419,0.130426451933116,0.186357287621569,"10018"
"GO:0005543~phospholipid binding",0.0118343195266272,7.57664851253911,7.17478197674419,0.0316704525297261,0.0923909903162971,"182, 6464"
"WP4906:3q29 copy number variation syndrome",0.00943396226415094,7.42009494417303,7.17478197674419,0.130426451933116,0.186357287621569,"3725"
"hsa03250_Viral_life_cycle",0.00943396226415094,7.42009494417303,7.17478197674419,0.130426451933116,0.186357287621569,"23299"
"GO:0000149~SNARE binding",0.00934579439252336,7.30400988007896,7.06440071556351,0.132326338248185,0.188559049800306,"8675"
"WP3651:Pathways affected in adenoid cystic carcinoma",0.00934579439252336,7.30400988007896,7.06440071556351,0.132326338248185,0.188559049800306,"546"
"hsa04926_Relaxin_signaling_pathway",0.0116959064327485,7.45771091509342,7.06440071556351,0.0325830418342542,0.0933652253286993,"3725, 6464"
"GO:0030168~platelet activation",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"10672"
"GO:0031507~heterochromatin formation",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"8314"
"GO:0051216~cartilage development",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"5310"
"R-HSA-9614085~FOXO-mediated transcription",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"10018"
"R-HSA-5334118~DNA methylation",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"1786"
"hsa05321_Inflammatory_bowel_disease",0.00925925925925926,7.19155225031739,6.95736434108527,0.134222169927826,0.189887019574734,"3725"
"hsa05200_Pathways_in_cancer",0.0141093474426808,8.36335317901954,6.90505333100192,1.66476960712297e-05,0.001380882579382,"10018, 10672, 182, 2335, 3725, 5335, 6198, 6921"
"hsa05207_Chemical_carcinogenesis",0.0125,7.4242368148174,6.88779069767442,0.00938219091398446,0.0535736698566649,"182, 3725, 6198"
"GO:0030216~keratinocyte differentiation",0.00917431192660551,7.0825572131839,6.8535230822631,0.136113955419624,0.191702943468568,"182"
"WP1403:AMP activated protein kinase signaling",0.00917431192660551,7.0825572131839,6.8535230822631,0.136113955419624,0.191702943468568,"6198"
"hsa00010_Glycolysis_/_Gluconeogenesis",0.00917431192660551,7.0825572131839,6.8535230822631,0.136113955419624,0.191702943468568,"3939"
"hsa04650_Natural_killer_cell_mediated_cytotoxicity",0.0114285714285714,7.2307967965608,6.8535230822631,0.0344391180130922,0.0960638052896164,"5335, 6464"
"WP3303:RAC1 PAK1 p38 MMP2 pathway",0.00909090909090909,6.97686709783567,6.75273597811217,0.138001703153995,0.194014883292325,"2335"
"hsa05221_Acute_myeloid_leukemia",0.00909090909090909,6.97686709783567,6.75273597811217,0.138001703153995,0.194014883292325,"6198"
"hsa05203_Viral_carcinogenesis",0.0122448979591837,7.23913563850758,6.71979580260919,0.0100317635596225,0.0568707171581476,"2934, 3725, 55697"
"hsa04210_Apoptosis",0.0112359550561798,7.06955708759589,6.70344593447632,0.0358578080761332,0.0985636143352625,"10018, 3725"
"R-HSA-9670095~Inhibition of DNA recombination at telomere",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"546"
"WP1982:Sterol regulatory element binding proteins SREBP signaling",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"10484"
"WP5293:Acute myeloid leukemia",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"6198"
"WP5158:Urotensin II mediated signaling",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"2335"
"hsa04664_Fc_epsilon_RI_signaling_pathway",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"5335"
"hsa04910_Insulin_signaling_pathway",0.0111731843575419,7.0144072287956,6.65487023929896,0.0363357101122059,0.0985636143352625,"6198, 6464"
"hsa05031_Amphetamine_addiction",0.00900900900900901,6.87144823877087,6.65487023929896,0.139885421544216,0.1954427520866,"3725"
"hsa04915_Estrogen_signaling_pathway",0.0111111111111111,6.96307561287786,6.60699347498745,0.0368160938537551,0.0995234372444563,"3725, 6464"
"GO:0007507~heart development",0.012,7.06003022151926,6.55980066445183,0.0107070181224989,0.0581360021617923,"2335, 5310, 6464"
"GO:0001664~G protein-coupled receptor binding",0.00892857142857143,6.77200617418052,6.55980066445183,0.14176511898646,0.196847425130098,"10672"
"GO:0005518~collagen binding",0.00892857142857143,6.77200617418052,6.55980066445183,0.14176511898646,0.196847425130098,"2335"
"GO:0097110~scaffold protein binding",0.00892857142857143,6.77200617418052,6.55980066445183,0.14176511898646,0.196847425130098,"4638"
"R-HSA-1474228~Degradation of the extracellular matrix",0.0110497237569061,6.91249555627258,6.55980066445183,0.0372989467805337,0.100656061859796,"2335, 7077"
"R-HSA-167172~Transcription of the HIV genome",0.00892857142857143,6.77200617418052,6.55980066445183,0.14176511898646,0.196847425130098,"6921"
"WP2880:Glucocorticoid receptor pathway",0.00892857142857143,6.77200617418052,6.55980066445183,0.14176511898646,0.196847425130098,"3725"
"R-HSA-6811442~Intra-Golgi and retrograde Golgi-to-ER traffic",0.0119521912350598,7.02587233075912,6.5287115617767,0.0108451679159689,0.0581360021617923,"23299, 4074, 8675"
"GO:0007204~positive regulation of cytosolic calcium ion concentration",0.010989010989011,6.86264996332422,6.51327725548408,0.0377842564127958,0.101123513402811,"10672, 5310"
"KW-0037~Angiogenesis",0.010989010989011,6.86264996332422,6.51327725548408,0.0377842564127958,0.101123513402811,"2335, 6464"
"GO:0032088~negative regulation of NF-kappaB transcription factor activity",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"25855"
"GO:0009611~response to wounding",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"2335"
"GO:0045669~positive regulation of osteoblast differentiation",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"182"
"R-HSA-448424~Interleukin-17 signaling",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"3725"
"R-HSA-380259~Loss of Nlp from mitotic centrosomes",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"203068"
"R-HSA-380284~Loss of proteins required for interphase microtubule organization from the centrosome",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"203068"
"R-HSA-204005~COPII-mediated vesicle transport",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"10484"
"WP2359:Parkin ubiquitin proteasomal system pathway",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"203068"
"hsa04917_Prolactin_signaling_pathway",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"6464"
"hsa05230_Central_carbon_metabolism_in_cancer",0.00884955752212389,6.67543490499834,6.46740910579758,0.143640803859831,0.197709962343314,"3939"
"GO:0006909~phagocytosis",0.0087719298245614,6.58130246052749,6.37758397932817,0.145512484526398,0.199415370098786,"63916"
"GO:0007015~actin filament organization",0.0108108108108108,6.71735565806572,6.37758397932817,0.0392548013502326,0.102937715354354,"2934, 63916"
"GO:0071466~cellular response to xenobiotic stimulus",0.0087719298245614,6.58130246052749,6.37758397932817,0.145512484526398,0.199415370098786,"4659"
"GO:0019904~protein domain specific binding",0.01171875,6.85992428801851,6.37758397932817,0.0115514912953148,0.0615038860858653,"203068, 4074, 5310"
"GO:0035064~methylated histone binding",0.0087719298245614,6.58130246052749,6.37758397932817,0.145512484526398,0.199415370098786,"546"
"GO:1990841~promoter-specific chromatin binding",0.0087719298245614,6.58130246052749,6.37758397932817,0.145512484526398,0.199415370098786,"1786"
"WP4255:Non small cell lung cancer",0.0087719298245614,6.58130246052749,6.37758397932817,0.145512484526398,0.199415370098786,"5335"
"R-HSA-1980143~Signaling by NOTCH1",0.00869565217391304,6.4895787587222,6.29021981522778,0.147380169331225,0.200926597634958,"182"
"R-HSA-199992~trans-Golgi Network Vesicle Budding",0.00869565217391304,6.4895787587222,6.29021981522778,0.147380169331225,0.200926597634958,"4074"
"WP4674:Head and neck squamous cell carcinoma",0.00869565217391304,6.4895787587222,6.29021981522778,0.147380169331225,0.200926597634958,"54541"
"hsa00562_Inositol_phosphate_metabolism",0.00869565217391304,6.4895787587222,6.29021981522778,0.147380169331225,0.200926597634958,"5335"
"hsa05223_Non-small_cell_lung_cancer",0.00869565217391304,6.4895787587222,6.29021981522778,0.147380169331225,0.200926597634958,"5335"
"WP5087:Pleural mesothelioma",0.0126050420168067,7.21327000549486,6.27589129628649,0.000354491282917346,0.0112174024537995,"2335, 3725, 6198, 6464, 8314, 9448"
"R-HSA-8856828~Clathrin-mediated endocytosis",0.0105820105820106,6.53209766672517,6.20521684475173,0.0412491717479797,0.106397208960419,"10094, 4074"
"R-HSA-9710421~Defective pyroptosis",0.00862068965517241,6.40036598319635,6.20521684475173,0.149243866602411,0.202591157420671,"1786"
"R-HSA-8854518~AURKA Activation by TPX2",0.00862068965517241,6.40036598319635,6.20521684475173,0.149243866602411,0.202591157420671,"203068"
"R-HSA-1169408~ISG15 antiviral mechanism",0.00862068965517241,6.40036598319635,6.20521684475173,0.149243866602411,0.202591157420671,"5335"
"R-HSA-212300~PRC2 methylates histones and DNA",0.00862068965517241,6.40036598319635,6.20521684475173,0.149243866602411,0.202591157420671,"1786"
"R-HSA-9013408~RHOG GTPase cycle",0.00862068965517241,6.40036598319635,6.20521684475173,0.149243866602411,0.202591157420671,"63916"
"hsa05226_Gastric_cancer",0.0105263157894737,6.48733658760674,6.16357109411581,0.0417536905771509,0.106613549230258,"6198, 6464"
"GO:0006898~receptor-mediated endocytosis",0.00854700854700855,6.31356270606652,6.12248062015504,0.151103584651117,0.204586984029347,"4074"
"GO:0009791~post-embryonic development",0.00854700854700855,6.31356270606652,6.12248062015504,0.151103584651117,0.204586984029347,"10018"
"GO:0019003~GDP binding",0.00854700854700855,6.31356270606652,6.12248062015504,0.151103584651117,0.204586984029347,"57826"
"GO:0008217~regulation of blood pressure",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"10672"
"GO:0009966~regulation of signal transduction",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"9448"
"R-HSA-3000178~ECM proteoglycans",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"2335"
"R-HSA-9013694~Signaling by NOTCH4",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"182"
"R-HSA-9659379~Sensory processing of sound",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"2934"
"WP4341:Non genomic actions of 1 25 dihydroxyvitamin D3",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"3725"
"hsa04971_Gastric_acid_secretion",0.00847457627118644,6.22907294948104,6.04192166462668,0.152959331771605,0.2056979479272,"4638"
"R-HSA-9006934~Signaling by Receptor Tyrosine Kinases",0.012280701754386,7.07246521911814,6.01929274453445,0.000140865921497403,0.00516289982046294,"10818, 1786, 2335, 529, 5335, 63916, 6464"
"GO:0001558~regulation of cell growth",0.00840336134453781,6.14680580977427,5.96345514950166,0.154811116241269,0.207644526975523,"8314"
"WP4396:Nonalcoholic fatty liver disease",0.0102564102564103,6.27236152864361,5.96345514950166,0.0443112365801197,0.108694664255265,"10018, 3725"
"hsa05212_Pancreatic_cancer",0.00840336134453781,6.14680580977427,5.96345514950166,0.154811116241269,0.207644526975523,"6198"
"hsa05220_Chronic_myeloid_leukemia",0.00840336134453781,6.14680580977427,5.96345514950166,0.154811116241269,0.207644526975523,"6464"
"GO:0042127~regulation of cell population proliferation",0.0102040816326531,6.23105209692937,5.92498124531133,0.0448296521357373,0.108694664255265,"182, 3725"
"GO:0042060~wound healing",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"2335"
"GO:0045727~positive regulation of translation",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"6198"
"GO:0005085~guanyl-nucleotide exchange factor activity",0.0109489051094891,6.32005893434922,5.88700059630292,0.0143113142750659,0.0680123336499054,"10672, 5335, 54453"
"R-HSA-5693565~Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"8314"
"R-HSA-73887~Death Receptor Signaling",0.0101522842639594,6.19029522310292,5.88700059630292,0.0453503419864428,0.109451973921338,"10018, 10672"
"WP289:Myometrial relaxation and contraction pathways",0.0101522842639594,6.19029522310292,5.88700059630292,0.0453503419864428,0.109451973921338,"3725, 5335"
"hsa04721_Synaptic_vesicle_cycle",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"529"
"hsa04932_Non-alcoholic_fatty_liver_disease",0.0101522842639594,6.19029522310292,5.88700059630292,0.0453503419864428,0.109451973921338,"10018, 3725"
"hsa05133_Pertussis",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"3725"
"hsa05140_Leishmaniasis",0.00833333333333333,6.06669107025598,5.88700059630292,0.156658946320668,0.208878595094224,"3725"
"GO:0051726~regulation of cell cycle",0.0108695652173913,6.26519826713208,5.83711076074103,0.0146391234569927,0.0680123336499054,"3725, 5310, 8314"
"GO:0051028~mRNA transport",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"23299"
"GO:0007018~microtubule-based movement",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"23299"
"GO:0006470~protein dephosphorylation",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"4659"
"R-HSA-9662851~Anti-inflammatory response favouring Leishmania parasite infection",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"5335"
"R-HSA-5693606~DNA Double Strand Break Response",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"8314"
"R-HSA-6806834~Signaling by MET",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"2335"
"R-HSA-9664433~Leishmania parasite growth and survival",0.00826446280991736,5.98863253331528,5.81248160141301,0.158502830253561,0.210092902001356,"5335"
"GO:0000082~G1/S transition of mitotic cell cycle",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"6198"
"GO:0009636~response to toxic substance",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"6198"
"GO:0048009~insulin-like growth factor receptor signaling pathway",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"6464"
"R-HSA-416482~G alpha (12/13) signalling events",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"10672"
"R-HSA-3000171~Non-integrin membrane-ECM interactions",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"2335"
"R-HSA-674695~RNA Polymerase II Pre-transcription Events",0.00813008130081301,5.83837299640321,5.66896353718059,0.16217879257106,0.213707171481597,"6921"
"GO:0042981~regulation of apoptotic process",0.0104895104895105,6.00436876574746,5.59982983550766,0.0163422276671352,0.0722909802555966,"10018, 10818, 25855"
"R-HSA-5628897~TP53 Regulates Metabolic Genes",0.00806451612903226,5.76602691049517,5.59982983550766,0.164010887359477,0.21540096539878,"54541"
"R-HSA-380270~Recruitment of mitotic centrosome proteins and complexes",0.00806451612903226,5.76602691049517,5.59982983550766,0.164010887359477,0.21540096539878,"203068"
"R-HSA-380287~Centrosome maturation",0.00806451612903226,5.76602691049517,5.59982983550766,0.164010887359477,0.21540096539878,"203068"
"WP2261:Glioblastoma signaling",0.00806451612903226,5.76602691049517,5.59982983550766,0.164010887359477,0.21540096539878,"5335"
"WP2005:miR targeted genes in muscle cell",0.0108108108108108,6.07551574720518,5.54907609077496,0.00572065391944011,0.0431705559545522,"10484, 10672, 546, 9782"
"GO:0001889~liver development",0.008,5.69544576739654,5.53236200616419,0.16583906880908,0.217258829961022,"5310"
"R-HSA-109581~Apoptosis",0.00966183574879227,5.80998889384374,5.53236200616419,0.050679739537902,0.115498752602284,"10018, 2934"
"WP1544:MicroRNAs in cardiomyocyte hypertrophy",0.008,5.69544576739654,5.53236200616419,0.16583906880908,0.217258829961022,"4638"
"hsa03083_Polycomb_repressive_complex",0.008,5.69544576739654,5.53236200616419,0.16583906880908,0.217258829961022,"8314"
"hsa05165_Human_papillomavirus_infection",0.0107816711590297,6.05668638396453,5.53236200616419,0.00578135445784192,0.0431705559545522,"182, 2335, 529, 6198"
"GO:0016192~vesicle-mediated transport",0.0103092783505155,5.88184273935089,5.48827944037802,0.0172339801218828,0.0722909802555966,"10484, 54453, 8675"
"GO:0003924~GTPase activity",0.0106666666666667,5.98250311656249,5.46650055370986,0.00602847462617092,0.0431705559545522,"10672, 203068, 57826, 989"
"GO:0030165~PDZ domain binding",0.00793650793650794,5.62656554033804,5.46650055370986,0.167663345080122,0.219284175806035,"6198"
"R-HSA-1483255~PI Metabolism",0.00793650793650794,5.62656554033804,5.46650055370986,0.167663345080122,0.219284175806035,"55697"
"hsa04140_Autophagy",0.00956937799043062,5.73942692135747,5.46650055370986,0.0517717415596405,0.117062072737437,"54541, 6198"
"WP4172:PI3K Akt signaling",0.0105820105820106,5.92802807275899,5.41812444261508,0.00621838652915235,0.0431705559545522,"10018, 2335, 54541, 6198"
"GO:0042147~retrograde transport, endosome to Golgi",0.0078740157480315,5.55932526437979,5.40218878248974,0.169483724316251,0.221114527750341,"8675"
"R-HSA-216083~Integrin cell surface interactions",0.0078740157480315,5.55932526437979,5.40218878248974,0.169483724316251,0.221114527750341,"2335"
"R-HSA-2219530~Constitutive Signaling by Aberrant PI3K in Cancer",0.0078740157480315,5.55932526437979,5.40218878248974,0.169483724316251,0.221114527750341,"10818"
"GO:0060326~cell chemotaxis",0.0078125,5.49444030174649,5.33937263385614,0.171300214644553,0.222930750024621,"63916"
"GO:0051117~ATPase binding",0.0078125,5.49444030174649,5.33937263385614,0.171300214644553,0.222930750024621,"529"
"WP4336:ncRNAs in Wnt signaling in hepatocellular carcinoma",0.0078125,5.49444030174649,5.33937263385614,0.171300214644553,0.222930750024621,"3725"
"GO:0030182~neuron differentiation",0.00930232558139535,5.53831087488489,5.27800053461641,0.0550983443876596,0.119700144960946,"51335, 54541"
"GO:0043547~positive regulation of GTPase activity",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"9448"
"GO:0005546~phosphatidylinositol-4,5-bisphosphate binding",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"2934"
"WP2840:Hair follicle development cytodifferentiation stage 3 of 3",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"3725"
"WP138:Androgen receptor signaling",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"3725"
"WP2446:Retinoblastoma gene in cancer",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"1786"
"hsa04662_B_cell_receptor_signaling_pathway",0.00775193798449612,5.43032561240168,5.27800053461641,0.173112824175571,0.224178973624239,"3725"
"R-HSA-76002~Platelet activation, signaling and aggregation",0.00986842105263158,5.58591642755618,5.21802325581395,0.0196786420526685,0.0769566746278055,"10672, 2335, 6464"
"R-HSA-5689603~UCH proteinases",0.00769230769230769,5.36767975678243,5.21802325581395,0.174921561003349,0.225779181114888,"8314"
"WP5234:Bardet Biedl syndrome",0.00769230769230769,5.36767975678243,5.21802325581395,0.174921561003349,0.225779181114888,"5310"
"WP5094:Orexin receptor pathway",0.00769230769230769,5.36767975678243,5.21802325581395,0.174921561003349,0.225779181114888,"6198"
"WP477:Cytoplasmic ribosomal proteins",0.00769230769230769,5.36767975678243,5.21802325581395,0.174921561003349,0.225779181114888,"6198"
"GO:0001525~angiogenesis",0.00980392156862745,5.54289155734409,5.17878999825144,0.0200709592361193,0.0782966132577327,"182, 2335, 6464"
"KW-0811~Translocation",0.00763358778625954,5.3064521888247,5.15939378102953,0.176726433205457,0.227363966311674,"23299"
"WP231:TNF alpha signaling",0.00763358778625954,5.3064521888247,5.15939378102953,0.176726433205457,0.227363966311674,"3725"
"WP4263:Pancreatic adenocarcinoma pathway",0.00763358778625954,5.3064521888247,5.15939378102953,0.176726433205457,0.227363966311674,"6198"
"hsa04512_ECM-receptor_interaction",0.00763358778625954,5.3064521888247,5.15939378102953,0.176726433205457,0.227363966311674,"2335"
"R-HSA-5673001~RAF/MAP kinase cascade",0.00970873786407767,5.47956322773453,5.12103397596611,0.0206675594902602,0.079242118645001,"10818, 2335, 6464"
"GO:0006816~calcium ion transport",0.00757575757575758,5.24659471351935,5.10206718346253,0.178527448843032,0.228933490135572,"5310"
"GO:0005262~calcium channel activity",0.00757575757575758,5.24659471351935,5.10206718346253,0.178527448843032,0.228933490135572,"5310"
"R-HSA-8876198~RAB GEFs exchange GTP for GDP on RABs",0.00757575757575758,5.24659471351935,5.10206718346253,0.178527448843032,0.228933490135572,"54453"
"hsa04211_Longevity_regulating_pathway",0.00757575757575758,5.24659471351935,5.10206718346253,0.178527448843032,0.228933490135572,"6198"
"hsa04151_PI3K-Akt_signaling_pathway",0.00997506234413965,5.54130007324357,5.07387896697931,0.00780851211452808,0.0492645630432988,"10018, 2335, 54541, 6198"
"WP35:G protein signaling",0.0075187969924812,5.1880613614449,5.04600051111679,0.1803246159608,0.230862384040797,"10672"
"R-HSA-5684996~MAPK1/MAPK3 signaling",0.00955414012738853,5.37702948878877,5.02758445085724,0.0216835765419659,0.0793588806942989,"10818, 2335, 6464"
"GO:0032869~cellular response to insulin stimulus",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"6198"
"GO:0008168~methyltransferase activity",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"1786"
"R-HSA-2682334~EPH-Ephrin signaling",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"10094"
"WP4223:Ras signaling",0.00888888888888889,5.23135383921805,4.99115267947422,0.0608059692616924,0.127977640651835,"5335, 6464"
"WP3925:Amino acid metabolism",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"3939"
"WP2355:Corticotropin releasing hormone signaling",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"5335"
"WP5355:Metabolic epileptic disorders",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"3939"
"WP4963:p53 transcriptional gene network",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"54541"
"hsa04540_Gap_junction",0.00746268656716418,5.13080497068174,4.99115267947422,0.18211794258712,0.23165284706804,"203068"
"GO:0006351~DNA-templated transcription",0.00740740740740741,5.07455969051564,4.93748437109277,0.183907436734006,0.232988842679095,"1786"
"R-HSA-9860931~Response of endothelial cells to shear stress",0.00740740740740741,5.07455969051564,4.93748437109277,0.183907436734006,0.232988842679095,"2335"
"R-HSA-9013149~RAC1 GTPase cycle",0.00881057268722467,5.17338858819334,4.93748437109277,0.0619711950926557,0.129188628923314,"10672, 182"
"hsa04912_GnRH_signaling_pathway",0.00740740740740741,5.07455969051564,4.93748437109277,0.183907436734006,0.232988842679095,"3725"
"hsa05222_Small_cell_lung_cancer",0.00740740740740741,5.07455969051564,4.93748437109277,0.183907436734006,0.232988842679095,"2335"
"GO:0005096~GTPase activator activity",0.009375,5.25871992771105,4.91985049833887,0.0229386053413363,0.0813827835766491,"10484, 3725, 54453"
"GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway",0.00735294117647059,5.01922223861007,4.88495794161306,0.185693106397167,0.234497063847704,"25855"
"R-HSA-69275~G2/M Transition",0.00873362445414847,5.11750589376216,4.88495794161306,0.0631441192103642,0.129674798636113,"203068, 4659"
"R-HSA-72764~Eukaryotic Translation Termination",0.00735294117647059,5.01922223861007,4.88495794161306,0.185693106397167,0.234497063847704,"51504"
"KW-0358~Heparin-binding",0.00735294117647059,5.01922223861007,4.88495794161306,0.185693106397167,0.234497063847704,"2335"
"WP4258:lncRNA in canonical Wnt signaling and colorectal cancer",0.00735294117647059,5.01922223861007,4.88495794161306,0.185693106397167,0.234497063847704,"3725"
"R-HSA-381119~Unfolded Protein Response (UPR)",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"6464"
"R-HSA-453274~Mitotic G2-G2/M phases",0.00865800865800866,5.06298552581897,4.83353733170135,0.0643246561882278,0.131298340967229,"203068, 4659"
"R-HSA-9013423~RAC3 GTPase cycle",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"182"
"R-HSA-3214815~HDACs deacetylate histones",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"25855"
"KW-0009~Actin-binding",0.00923076923076923,5.16317512167111,4.83353733170135,0.0240143205292303,0.0822751503349283,"10094, 2934, 4638"
"WP4658:Small cell lung cancer",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"2335"
"WP75:Toll like receptor signaling",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"3725"
"hsa04657_IL-17_signaling_pathway",0.0072992700729927,4.96596037885551,4.83353733170135,0.187474959556036,0.235239280462032,"3725"
"GO:0005525~GTP binding",0.00945626477541371,5.21373921223765,4.78318798449612,0.00956157888777588,0.0544008964878512,"10672, 203068, 57826, 989"
"GO:0042393~histone binding",0.00858369098712446,5.00794408645451,4.78318798449612,0.0655127211661151,0.131358840404322,"546, 8028"
"GO:0004386~helicase activity",0.0072463768115942,4.91381705336434,4.78318798449612,0.189253004173802,0.237092793782123,"546"
"R-HSA-5625740~RHO GTPases activate PKNs",0.0072463768115942,4.91381705336434,4.78318798449612,0.189253004173802,0.237092793782123,"4659"
"GO:0060090~molecular adaptor activity",0.00854700854700855,4.98158709332237,4.7584046270635,0.0661095502903987,0.132219100580797,"182, 989"
"hsa04062_Chemokine_signaling_pathway",0.00854700854700855,4.98158709332237,4.7584046270635,0.0661095502903987,0.132219100580797,"5335, 6464"
"GO:0016525~negative regulation of angiogenesis",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"6464"
"GO:0050727~regulation of inflammatory response",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"8314"
"GO:0008233~peptidase activity",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"8314"
"R-HSA-975871~MyD88 cascade initiated on plasma membrane",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"3725"
"R-HSA-168142~Toll Like Receptor 10 (TLR10) Cascade",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"3725"
"R-HSA-168176~Toll Like Receptor 5 (TLR5) Cascade",0.00719424460431655,4.86119525476399,4.73387676816111,0.191027248197442,0.238179543638583,"3725"
"hsa05167_Kaposi_sarcoma-associated_herpesvirus_infection",0.00847457627118644,4.92963624681566,4.70960047704234,0.0673087493870209,0.132521123585704,"3725, 5335"
"GO:0007179~transforming growth factor beta receptor signaling pathway",0.00714285714285714,4.81101693249684,4.68557190317988,0.19279769955776,0.239628686516585,"3725"
"R-HSA-9833110~RSV-host interactions",0.00714285714285714,4.81101693249684,4.68557190317988,0.19279769955776,0.239628686516585,"6921"
"hsa04070_Phosphatidylinositol_signaling_system",0.00714285714285714,4.81101693249684,4.68557190317988,0.19279769955776,0.239628686516585,"5335"
"R-HSA-2559583~Cellular Senescence",0.00836820083682008,4.85360095695348,4.63824289405685,0.0691212439300032,0.133521755591922,"3725, 9448"
"R-HSA-5620912~Anchoring of the basal body to the plasma membrane",0.00709219858156028,4.76180498261097,4.63824289405685,0.194564366169406,0.240685589547083,"203068"
"R-HSA-380320~Recruitment of NuMA to mitotic centrosomes",0.00709219858156028,4.76180498261097,4.63824289405685,0.194564366169406,0.240685589547083,"203068"
"R-HSA-1912408~Pre-NOTCH Transcription and Translation",0.00709219858156028,4.76180498261097,4.63824289405685,0.194564366169406,0.240685589547083,"3725"
"KW-0931~ER-Golgi transport",0.00709219858156028,4.76180498261097,4.63824289405685,0.194564366169406,0.240685589547083,"10484"
"hsa04750_Inflammatory_mediator_regulation_of_TRP_channels",0.00709219858156028,4.76180498261097,4.63824289405685,0.194564366169406,0.240685589547083,"5335"
"R-HSA-5357801~Programmed Cell Death",0.00833333333333333,4.82875294474094,4.61493514082038,0.0697290196007234,0.133852539452789,"10018, 2934"
"GO:0004672~protein kinase activity",0.00884955752212389,4.91606360387047,4.6072178579762,0.0271707227649466,0.0876003871619762,"4638, 6198, 9448"
"WP3932:Focal adhesion PI3K Akt mTOR signaling",0.0087463556851312,4.84957146339239,4.54639650011513,0.0281116050054361,0.0876003871619762,"2335, 54541, 6198"
"WP185:Integrin mediated cell adhesion",0.00699300699300699,4.66623073112501,4.54639650011513,0.19808637672476,0.244850297818213,"6464"
"GO:0043410~positive regulation of MAPK cascade",0.00819672131147541,4.73178204938249,4.52400045824264,0.0721779025877997,0.137216374521559,"10818, 6464"
"GO:0008543~fibroblast growth factor receptor signaling pathway",0.00694444444444444,4.61983312220191,4.50182398540812,0.199841736417329,0.246247518837929,"10818"
"R-HSA-9006925~Intracellular signaling by second messengers",0.00867052023121387,4.8008414988922,4.50182398540812,0.0288286411692523,0.089249225759137,"10818, 3725, 5335"
"KW-0442~Lipid degradation",0.00694444444444444,4.61983312220191,4.50182398540812,0.199841736417329,0.246247518837929,"5335"
"KW-0698~rRNA processing",0.00694444444444444,4.61983312220191,4.50182398540812,0.199841736417329,0.246247518837929,"51504"
"WP399:Wnt signaling and pluripotency",0.00694444444444444,4.61983312220191,4.50182398540812,0.199841736417329,0.246247518837929,"3725"
"hsa05169_Epstein-Barr_virus_infection",0.00816326530612245,4.70813090170867,4.50182398540812,0.0727945174565275,0.138115802722602,"10018, 3725"
"R-HSA-194315~Signaling by Rho GTPases",0.00932090545938748,5.21625070665964,4.49552772808587,0.000819765310676883,0.0165634632003432,"10094, 10672, 10818, 182, 4638, 4659, 63916"
"WP2004:miR targeted genes in lymphocytes",0.0089086859688196,4.87326137715369,4.47986386840613,0.0119433906660079,0.0628335834008719,"10484, 10672, 546, 9782"
"R-HSA-9855142~Cellular responses to mechanical stimuli",0.00689655172413793,4.57433424602494,4.45811695642357,0.201593342859016,0.247631417260958,"2335"
"R-HSA-975138~TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.00689655172413793,4.57433424602494,4.45811695642357,0.201593342859016,0.247631417260958,"3725"
"hsa05142_Chagas_disease",0.00689655172413793,4.57433424602494,4.45811695642357,0.201593342859016,0.247631417260958,"3725"
"hsa05146_Amoebiasis",0.00689655172413793,4.57433424602494,4.45811695642357,0.201593342859016,0.247631417260958,"2335"
"R-HSA-5617833~Cilium Assembly",0.00806451612903226,4.63817147528142,4.43658015953264,0.0746547461277089,0.139583361431852,"203068, 5310"
"R-HSA-9856651~MITF-M-dependent gene expression",0.00684931506849315,4.52933483330987,4.41525044722719,0.20334120388422,0.249002126900956,"529"
"R-HSA-975155~MyD88 dependent cascade initiated on endosome",0.00684931506849315,4.52933483330987,4.41525044722719,0.20334120388422,0.249002126900956,"3725"
"hsa04137_Mitophagy",0.00684931506849315,4.52933483330987,4.41525044722719,0.20334120388422,0.249002126900956,"3725"
"R-HSA-9716542~Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.0091264667535854,5.0960034084732,4.39713040435211,0.000933308604924373,0.0179930574196222,"10094, 10672, 10818, 182, 4638, 4659, 63916"
"GO:0016042~lipid catabolic process",0.00680272108843537,4.48650217676363,4.37320044296789,0.205085327311387,0.24997252578712,"5335"
"R-HSA-428157~Sphingolipid metabolism",0.00680272108843537,4.48650217676363,4.37320044296789,0.205085327311387,0.24997252578712,"4074"
"KW-0509~mRNA transport",0.00680272108843537,4.48650217676363,4.37320044296789,0.205085327311387,0.24997252578712,"23299"
"hsa04064_NF-kappa_B_signaling_pathway",0.00680272108843537,4.48650217676363,4.37320044296789,0.205085327311387,0.24997252578712,"5335"
"hsa04625_C-type_lectin_receptor_signaling_pathway",0.00680272108843537,4.48650217676363,4.37320044296789,0.205085327311387,0.24997252578712,"3725"
"KW-0156~Chromatin regulator",0.00842696629213483,4.64547267354166,4.35936120105976,0.0312890531772097,0.0923437224855477,"1786, 546, 8314"
"R-HSA-168164~Toll Like Receptor 3 (TLR3) Cascade",0.00675675675675676,4.4433500823734,4.33194383501536,0.206825720943037,0.251704506722955,"3725"
"hsa04922_Glucagon_signaling_pathway",0.00675675675675676,4.4433500823734,4.33194383501536,0.206825720943037,0.251704506722955,"3939"
"R-HSA-8856825~Cargo recognition for clathrin-mediated endocytosis",0.00671140939597315,4.40107978423431,4.29145837861334,0.208562392565801,0.253622168737424,"4074"
"GO:0051015~actin filament binding",0.0078125,4.46268221488083,4.27149810708491,0.0796897493610166,0.143861449018284,"10094, 2934"
"R-HSA-199991~Membrane Trafficking",0.00878477306002928,4.82947901051106,4.26488588091295,0.00260577586292098,0.0301963438232608,"10094, 10484, 23299, 4074, 54453, 8675"
"R-HSA-168181~Toll Like Receptor 7/8 (TLR7/8) Cascade",0.00666666666666667,4.35964749364526,4.25172265288544,0.210295349950446,0.2547467113927,"3725"
"R-HSA-427413~NoRC negatively regulates rRNA expression",0.00666666666666667,4.35964749364526,4.25172265288544,0.210295349950446,0.2547467113927,"1786"
"R-HSA-202403~TCR signaling",0.00666666666666667,4.35964749364526,4.25172265288544,0.210295349950446,0.2547467113927,"5335"
"hsa04350_TGF-beta_signaling_pathway",0.00666666666666667,4.35964749364526,4.25172265288544,0.210295349950446,0.2547467113927,"6198"
"hsa05417_Lipid_and_atherosclerosis",0.00778210116731518,4.44157186415115,4.25172265288544,0.0803265555111634,0.144845138999535,"3725, 5335"
"R-HSA-422475~Axon guidance",0.00859106529209622,4.67788617418446,4.22045998632011,0.00632732545421155,0.0431705559545522,"10094, 10818, 5335, 6464, 6921"
"GO:0050852~T cell receptor signaling pathway",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"5335"
"GO:0007229~integrin-mediated signaling pathway",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"2335"
"GO:0008584~male gonad development",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"10018"
"R-HSA-6785807~Interleukin-4 and Interleukin-13 signaling",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"2335"
"R-HSA-72306~tRNA processing",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"51504"
"WP2263:Androgen receptor network in prostate cancer",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"3725"
"hsa04620_Toll-like_receptor_signaling_pathway",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"3725"
"hsa04931_Insulin_resistance",0.00662251655629139,4.31901548941508,4.21271602304246,0.212024600851914,0.255271788344245,"6198"
"GO:0003690~double-stranded DNA binding",0.00657894736842105,4.27915098592298,4.17441860465116,0.213750153009348,0.256760854529522,"3725"
"R-HSA-8957275~Post-translational protein phosphorylation",0.00657894736842105,4.27915098592298,4.17441860465116,0.213750153009348,0.256760854529522,"2335"
"WP4874:CAMKK2 pathway",0.00657894736842105,4.27915098592298,4.17441860465116,0.213750153009348,0.256760854529522,"6198"
"R-HSA-195258~RHO GTPase Effectors",0.00808625336927224,4.42932300625793,4.16180706808122,0.0351816602327614,0.0977888827633719,"10094, 4638, 4659"
"GO:0048018~receptor ligand activity",0.0065359477124183,4.24002520879428,4.13681122983449,0.215472014146124,0.257846540846083,"2335"
"R-HSA-5250941~Negative epigenetic regulation of rRNA expression",0.0065359477124183,4.24002520879428,4.13681122983449,0.215472014146124,0.257846540846083,"1786"
"R-HSA-166166~MyD88-independent TLR4 cascade ",0.0065359477124183,4.24002520879428,4.13681122983449,0.215472014146124,0.257846540846083,"3725"
"R-HSA-168138~Toll Like Receptor 9 (TLR9) Cascade",0.0065359477124183,4.24002520879428,4.13681122983449,0.215472014146124,0.257846540846083,"3725"
"R-HSA-937061~TRIF (TICAM1)-mediated TLR4 signaling ",0.0065359477124183,4.24002520879428,4.13681122983449,0.215472014146124,0.257846540846083,"3725"
"GO:0035264~multicellular organism growth",0.00649350649350649,4.20161264132902,4.09987541528239,0.217190191969885,0.258723917267225,"546"
"GO:0036211~protein modification process",0.00649350649350649,4.20161264132902,4.09987541528239,0.217190191969885,0.258723917267225,"8314"
"R-HSA-2219528~PI3K/AKT Signaling in Cancer",0.00649350649350649,4.20161264132902,4.09987541528239,0.217190191969885,0.258723917267225,"10818"
"R-HSA-156580~Phase II - Conjugation of compounds",0.00649350649350649,4.20161264132902,4.09987541528239,0.217190191969885,0.258723917267225,"51504"
"WP5426:HDAC6 interactions in the central nervous system",0.00649350649350649,4.20161264132902,4.09987541528239,0.217190191969885,0.258723917267225,"203068"
"hsa05166_Human_T-cell_leukemia_virus_1_infection",0.00754716981132075,4.27970002021678,4.09987541528239,0.0854784707119914,0.151052978984073,"3725, 55697"
"GO:0019722~calcium-mediated signaling",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"5335"
"R-HSA-977225~Amyloid fiber formation",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"2934"
"R-HSA-166058~MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"3725"
"R-HSA-6811558~PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"10818"
"R-HSA-2559582~Senescence-Associated Secretory Phenotype (SASP)",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"3725"
"R-HSA-168188~Toll Like Receptor TLR6:TLR2 Cascade",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"3725"
"WP3391:Senescence associated secretory phenotype SASP ",0.00645161290322581,4.16389041136479,4.06359333196131,0.218904694172568,0.259393833094713,"3725"
"hsa04024_cAMP_signaling_pathway",0.00749063670411985,4.24101817276782,4.06359333196131,0.0867820620931982,0.1526938507099,"3725, 4659"
"hsa05163_Human_cytomegalovirus_infection",0.00749063670411985,4.24101817276782,4.06359333196131,0.0867820620931982,0.1526938507099,"10672, 6198"
"R-HSA-1280215~Cytokine Signaling in Immune system",0.00844390832328106,4.67895371283186,4.05334467286431,0.0014961784404512,0.0224569259252485,"10018, 2335, 3725, 5335, 54014, 6464, 6921"
"GO:0003779~actin binding",0.00789473684210526,4.30901641926326,4.05164158686731,0.0376328777026792,0.101123513402811,"10094, 2934, 4638"
"R-HSA-9012999~RHO GTPase cycle",0.00811359026369168,4.38729458019137,4.04569203975003,0.0167885982427895,0.0722909802555966,"10672, 10818, 182, 63916"
"R-HSA-9675108~Nervous system development",0.00823723228995058,4.46457217225821,4.03502677075244,0.00761719163363041,0.0484060242524255,"10094, 10818, 5335, 6464, 6921"
"GO:0045471~response to ethanol",0.00641025641025641,4.12716200303901,4.02794777641779,0.220615528430442,0.260832762795482,"6198"
"R-HSA-157579~Telomere Maintenance",0.00641025641025641,4.12716200303901,4.02794777641779,0.220615528430442,0.260832762795482,"546"
"WP428:Wnt signaling",0.00641025641025641,4.12716200303901,4.02794777641779,0.220615528430442,0.260832762795482,"3725"
"R-HSA-5653656~Vesicle-mediated transport",0.00829875518672199,4.53518940434574,4.01620448843989,0.00350785986435146,0.036370968067223,"10094, 10484, 23299, 4074, 54453, 8675"
"R-HSA-1912422~Pre-NOTCH Expression and Processing",0.00636942675159236,4.09035295837694,3.99292214357937,0.222322702404131,0.26245736253851,"3725"
"hsa04928_Parathyroid_hormone_synthesis,_secretion_and_action",0.00636942675159236,4.09035295837694,3.99292214357937,0.222322702404131,0.26245736253851,"10672"
"R-HSA-157118~Signaling by NOTCH",0.00735294117647059,4.14741115463148,3.97563676633444,0.0900675381287534,0.154122084789268,"182, 3725"
"R-HSA-8951664~Neddylation",0.00732600732600733,4.12911167521055,3.95850040096231,0.0907291014217176,0.155000005249611,"57542, 6921"
"R-HSA-168179~Toll Like Receptor TLR1:TLR2 Cascade",0.00632911392405063,4.05460479405752,3.95850040096231,0.224026223738651,0.263875432445526,"3725"
"R-HSA-181438~Toll Like Receptor 2 (TLR2) Cascade",0.00632911392405063,4.05460479405752,3.95850040096231,0.224026223738651,0.263875432445526,"3725"
"KW-0053~Apoptosis",0.00809061488673139,4.37615941452268,3.95850040096231,0.00823928614933862,0.0501278199499169,"10018, 25855, 54541, 6198, 63916"
"hsa04670_Leukocyte_transendothelial_migration",0.00632911392405063,4.05460479405752,3.95850040096231,0.224026223738651,0.263875432445526,"5335"
"R-HSA-449147~Signaling by Interleukins",0.00793650793650794,4.27998765781434,3.94998749687422,0.0181673857538781,0.0753468419687154,"2335, 3725, 54014, 6464"
"GO:0035556~intracellular signal transduction",0.00792079207920792,4.27039890710038,3.94151112885518,0.0182961434998376,0.075681685448147,"5335, 54541, 6464, 9448"
"hsa04714_Thermogenesis",0.0072992700729927,4.11083708634885,3.94151112885518,0.0913921325549678,0.155000005249611,"10818, 6198"
"GO:0006511~ubiquitin-dependent protein catabolic process",0.00727272727272727,4.09361654326156,3.92466706420195,0.0920566223677256,0.155666563145424,"6921, 8314"
"GO:0007219~Notch signaling pathway",0.00628930817610063,4.01991311152979,3.92466706420195,0.225726100063438,0.265679114040312,"182"
"GO:0060271~cilium assembly",0.0072202166064982,4.05776744012025,3.89140717382736,0.0933899415447537,0.156175705293946,"2934, 989"
"GO:0001764~neuron migration",0.00625,3.98496361558003,3.89140717382736,0.22742233899238,0.266878336747573,"54541"
"GO:0008286~insulin receptor signaling pathway",0.00625,3.98496361558003,3.89140717382736,0.22742233899238,0.266878336747573,"6464"
"WP3931:Embryonic stem cell pluripotency pathways",0.00625,3.98496361558003,3.89140717382736,0.22742233899238,0.266878336747573,"3725"
"hsa05171_Coronavirus_disease",0.0072202166064982,4.05776744012025,3.89140717382736,0.0933899415447537,0.156175705293946,"3725, 5335"
"GO:0051056~regulation of small GTPase mediated signal transduction",0.0062111801242236,3.95099917646374,3.85870627320696,0.229114948123848,0.268066190232505,"10672"
"GO:0017124~SH3 domain binding",0.0062111801242236,3.95099917646374,3.85870627320696,0.229114948123848,0.268066190232505,"63916"
"WP4787:Osteoblast differentiation and related diseases",0.0062111801242236,3.95099917646374,3.85870627320696,0.229114948123848,0.268066190232505,"182"
"hsa04014_Ras_signaling_pathway",0.00716845878136201,4.02297440288963,3.85870627320696,0.0947289862897681,0.157814886250184,"5335, 6464"
"R-HSA-168249~Innate Immune System",0.00810810810810811,4.62234562828518,3.84077548197458,0.000431056371051389,0.0121311578710177,"10094, 203068, 2934, 3725, 529, 5335, 57826, 63916, 7077"
"GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport",0.00617283950617284,3.91760733139684,3.8265503875969,0.230803935040728,0.269043640254576,"10484"
"R-HSA-3700989~Transcriptional Regulation by TP53",0.0075,4.06348615768399,3.8265503875969,0.0433874574720731,0.108023116865698,"3725, 54541, 6921"
"R-HSA-199418~Negative regulation of the PI3K/AKT network",0.00617283950617284,3.91760733139684,3.8265503875969,0.230803935040728,0.269043640254576,"10818"
"R-HSA-162909~Host Interactions of HIV factors",0.00617283950617284,3.91760733139684,3.8265503875969,0.230803935040728,0.269043640254576,"6921"
"R-HSA-9820952~Respiratory Syncytial Virus Infection Pathway",0.00617283950617284,3.91760733139684,3.8265503875969,0.230803935040728,0.269043640254576,"6921"
"WP4541:Hippo Merlin signaling dysregulation",0.00617283950617284,3.91760733139684,3.8265503875969,0.230803935040728,0.269043640254576,"4659"
"GO:0007264~small GTPase-mediated signal transduction",0.00613496932515337,3.88477463989828,3.79492600422833,0.232489307310447,0.270607938198866,"54453"
"GO:0003682~chromatin binding",0.00764818355640535,4.1066759843742,3.79492600422833,0.0207123008845397,0.079242118645001,"1786, 546, 8028, 8314"
"GO:0005201~extracellular matrix structural constituent",0.00613496932515337,3.88477463989828,3.79492600422833,0.232489307310447,0.270607938198866,"2335"
"GO:0000165~MAPK cascade",0.00609756097560976,3.85248812577392,3.763820053374,0.234171072485011,0.271562627105503,"9448"
"R-HSA-6798695~Neutrophil degranulation",0.00759013282732448,4.07190254808373,3.763820053374,0.0212748035353474,0.079242118645001,"203068, 2934, 57826, 7077"
"KW-0646~Protease inhibitor",0.00609756097560976,3.85248812577392,3.763820053374,0.234171072485011,0.271562627105503,"7077"
"hsa04071_Sphingolipid_signaling_pathway",0.00609756097560976,3.85248812577392,3.763820053374,0.234171072485011,0.271562627105503,"10672"
"hsa04152_AMPK_signaling_pathway",0.00609756097560976,3.85248812577392,3.763820053374,0.234171072485011,0.271562627105503,"6198"
"hsa04919_Thyroid_hormone_signaling_pathway",0.00609756097560976,3.85248812577392,3.763820053374,0.234171072485011,0.271562627105503,"5335"
"GO:0006325~chromatin organization",0.00699300699300699,3.90572629574373,3.7484575225439,0.0994596942681693,0.158863906406898,"546, 8314"
"R-HSA-983169~Class I MHC mediated antigen processing & presentation",0.00735294117647059,3.97281667537026,3.74336450960566,0.0458068001429863,0.110384582607563,"10484, 57542, 6921"
"GO:0019901~protein kinase binding",0.00754716981132075,4.04619935343341,3.7408231895041,0.0217028411035805,0.0793588806942989,"10018, 4659, 5310, 5335"
"R-HSA-1643685~Disease",0.00798296966471527,5.21221364002324,3.7211186913422,4.29568272505241e-06,0.000752221774964733,"10018, 10094, 10484, 10818, 1786, 182, 203068, 2335, 25855, 3725, 5335, 546, 63916, 6464, 6921"
"GO:0004711~ribosomal protein S6 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0044022~histone H3S28 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0044023~histone H4S1 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0004676~3-phosphoinositide-dependent protein kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0072371~histone H2AS121 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0072354~histone H3T3 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0044024~histone H2AS1 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:1990244~histone H2AT120 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0140855~histone H3S57 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0035175~histone H3S10 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0072518~Rho-dependent protein serine/threonine kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0035979~histone H2AXS139 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0140823~histone H2BS36 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"GO:0044025~histone H2BS14 kinase activity",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"6198, 9448"
"WP382:MAPK signaling",0.00694444444444444,3.87346552621825,3.71810563977027,0.100823618088348,0.158863906406898,"3725, 9448"
"GO:0016579~protein deubiquitination",0.00602409638554217,3.78950367065687,3.70311327831958,0.237523811679751,0.27484399941798,"8314"
"GO:0004677~DNA-dependent protein kinase activity",0.0069204152249135,3.85753364749385,3.70311327831958,0.10150758486786,0.158863906406898,"6198, 9448"
"GO:0140857~histone H3T45 kinase activity",0.0069204152249135,3.85753364749385,3.70311327831958,0.10150758486786,0.158863906406898,"6198, 9448"
"R-HSA-5617472~Activation of anterior HOX genes in hindbrain development during early embryogenesis",0.00602409638554217,3.78950367065687,3.70311327831958,0.237523811679751,0.27484399941798,"3725"
"R-HSA-5619507~Activation of HOX genes during differentiation",0.00602409638554217,3.78950367065687,3.70311327831958,0.237523811679751,0.27484399941798,"3725"
"GO:0035403~histone H3T6 kinase activity",0.00689655172413793,3.84173206683958,3.68824133744279,0.10219287661527,0.15961939895507,"6198, 9448"
"GO:0035402~histone H3T11 kinase activity",0.00689655172413793,3.84173206683958,3.68824133744279,0.10219287661527,0.15961939895507,"6198, 9448"
"GO:0004674~protein serine/threonine kinase activity",0.0072463768115942,3.90739796773163,3.68331053351573,0.0476648980355749,0.11211922284189,"4638, 6198, 9448"
"GO:0004679~AMP-activated protein kinase activity",0.00687285223367698,3.82605927868846,3.67348837209302,0.102879484659253,0.160230595031669,"6198, 9448"
"R-HSA-9705671~SARS-CoV-2 activates/modulates innate and adaptive immune responses",0.00598802395209581,3.75878158553639,3.67348837209302,0.239194800727087,0.276169235125193,"10484"
"R-HSA-9007101~Rab regulation of trafficking",0.00598802395209581,3.75878158553639,3.67348837209302,0.239194800727087,0.276169235125193,"54453"
"GO:0042826~histone deacetylase binding",0.00591715976331361,3.6988195146364,3.61563816150888,0.242526055174774,0.27960575197911,"25855"
"R-HSA-381426~Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",0.00591715976331361,3.6988195146364,3.61563816150888,0.242526055174774,0.27960575197911,"2335"
"hsa04020_Calcium_signaling_pathway",0.00677966101694915,3.76462656767929,3.61563816150888,0.105638907417944,0.162109949455385,"4638, 5335"
"R-HSA-5663205~Infectious disease",0.00756143667296786,4.20769147050513,3.59089772443111,0.00145127381270778,0.0220705927166264,"10094, 10484, 203068, 25855, 3725, 5335, 63916, 6921"
"R-HSA-6807070~PTEN Regulation",0.00588235294117647,3.66955703612911,3.58739098837209,0.244186335510563,0.281314082430297,"3725"
"R-HSA-114608~Platelet degranulation ",0.00584795321637427,3.64075900313996,3.55958175590409,0.245843061185897,0.28280924410874,"2335"
"WP4217:Ebola virus infection in host",0.00584795321637427,3.64075900313996,3.55958175590409,0.245843061185897,0.28280924410874,"2934"
"GO:0051301~cell division",0.00700934579439252,3.76276303467469,3.55040757612083,0.0521443003583635,0.117735554963869,"203068, 57542, 989"
"GO:0006915~apoptotic process",0.0072992700729927,3.90602516917368,3.54857841199094,0.0128118426863838,0.0628335834008719,"10018, 25855, 54541, 6198, 63916"
"GO:0009653~anatomical structure morphogenesis",0.00581395348837209,3.6124147611491,3.53220035778175,0.247496239630483,0.284295972053675,"5310"
"KW-0254~Endocytosis",0.00581395348837209,3.6124147611491,3.53220035778175,0.247496239630483,0.284295972053675,"54453"
"KW-0723~Serine/threonine-protein kinase",0.00696055684454756,3.73314406079238,3.52316659727592,0.0531301388568223,0.117933942025848,"4638, 6198, 9448"
"R-HSA-168256~Immune System",0.00756143667296786,5.03879665087826,3.51698264441649,3.78490585835408e-06,0.000745626454095754,"10018, 10094, 10484, 203068, 2335, 2934, 3725, 529, 5335, 54014, 57542, 57826, 63916, 6464, 6921, 7077"
"R-HSA-2132295~MHC class II antigen presentation",0.00578034682080925,3.58451388152474,3.50523699627197,0.249145878258875,0.285982450208293,"10484"
"R-HSA-1257604~PIP3 activates AKT signaling",0.00655737704918033,3.61936104164311,3.47868217054264,0.112625423038027,0.169661594513238,"10818, 3725"
"GO:0004843~cysteine-type deubiquitinase activity",0.00571428571428571,3.52924121894331,3.45252666550096,0.252434565649708,0.289125636238329,"8314"
"hsa04068_FoxO_signaling_pathway",0.00571428571428571,3.52924121894331,3.45252666550096,0.252434565649708,0.289125636238329,"10018"
"hsa04142_Lysosome",0.00571428571428571,3.52924121894331,3.45252666550096,0.252434565649708,0.289125636238329,"4074"
"GO:0030335~positive regulation of cell migration",0.00647249190938511,3.56358189129969,3.42676154113155,0.115453807907912,0.17230606180196,"4638, 9448"
"R-HSA-76005~Response to elevated platelet cytosolic Ca2+",0.00568181818181818,3.50262150719041,3.42676154113155,0.254073629165773,0.290369861903741,"2335"
"KW-0810~Translation regulation",0.00568181818181818,3.50262150719041,3.42676154113155,0.254073629165773,0.290369861903741,"6198"
"GO:0070588~calcium ion transmembrane transport",0.00564971751412429,3.47640540429245,3.40137812230835,0.255709182372946,0.29181583737854,"5310"
"hsa00190_Oxidative_phosphorylation",0.00564971751412429,3.47640540429245,3.40137812230835,0.255709182372946,0.29181583737854,"529"
"hsa05012_Parkinson_disease",0.00643086816720257,3.53671606534096,3.40137812230835,0.116874975642479,0.17381008052147,"203068, 5335"
"GO:0016477~cell migration",0.00641025641025641,3.52343498037866,3.38882691152493,0.117587274995813,0.174211730542315,"5335, 6198"
"R-HSA-162599~Late Phase of HIV Life Cycle",0.00561797752808989,3.45053975837806,3.37636798905609,0.257341232610476,0.292407918236561,"6921"
"KW-0051~Antiviral defense",0.00561797752808989,3.45053975837806,3.37636798905609,0.257341232610476,0.292407918236561,"54541"
"WP5224:2q37 copy number variation syndrome",0.00561797752808989,3.45053975837806,3.37636798905609,0.257341232610476,0.292407918236561,"3725"
"WP4630:Measles virus infection",0.00561797752808989,3.45053975837806,3.37636798905609,0.257341232610476,0.292407918236561,"3725"
"GO:0008017~microtubule binding",0.00634920634920635,3.48414373276232,3.35172296723816,0.119730938684106,0.174880407197544,"10018, 9448"
"R-HSA-3247509~Chromatin modifying enzymes",0.00634920634920635,3.48414373276232,3.35172296723816,0.119730938684106,0.174880407197544,"25855, 54014"
"R-HSA-4839726~Chromatin organization",0.00634920634920635,3.48414373276232,3.35172296723816,0.119730938684106,0.174880407197544,"25855, 54014"
"GO:0006886~intracellular protein transport",0.00632911392405063,3.47120375976928,3.33953488372093,0.120447721865338,0.175764453388678,"10484, 8675"
"GO:0032496~response to lipopolysaccharide",0.00555555555555556,3.39982304589187,3.32743511964948,0.260594853458775,0.295465819461172,"6198"
"WP2858:Ectoderm differentiation",0.00555555555555556,3.39982304589187,3.32743511964948,0.260594853458775,0.295465819461172,"8675"
"hsa04380_Osteoclast_differentiation",0.00555555555555556,3.39982304589187,3.32743511964948,0.260594853458775,0.295465819461172,"3725"
"hsa05162_Measles",0.00552486187845304,3.37501547319398,3.30349673749373,0.262216438673304,0.297090659488949,"3725"
"R-HSA-9679506~SARS-CoV Infections",0.0065359477124183,3.47661642962372,3.2877282566465,0.0627647647368237,0.129674798636113,"10484, 203068, 25855"
"GO:0006468~protein phosphorylation",0.00623052959501558,3.40789924648964,3.27990033222591,0.124047996563015,0.179687171492014,"4638, 9448"
"R-HSA-8856688~Golgi-to-ER retrograde transport",0.00549450549450549,3.35056452760299,3.27990033222591,0.26383455012577,0.298494796122192,"23299"
"hsa05418_Fluid_shear_stress_and_atherosclerosis",0.00549450549450549,3.35056452760299,3.27990033222591,0.26383455012577,0.298494796122192,"3725"
"GO:0045766~positive regulation of angiogenesis",0.00543478260869565,3.30270219992883,3.23370455289879,0.267060380788449,0.301063776911728,"5335"
"GO:0044325~transmembrane transporter binding",0.00543478260869565,3.30270219992883,3.23370455289879,0.267060380788449,0.301063776911728,"5310"
"R-HSA-73886~Chromosome Maintenance",0.00543478260869565,3.30270219992883,3.23370455289879,0.267060380788449,0.301063776911728,"546"
"KW-0347~Helicase",0.00543478260869565,3.30270219992883,3.23370455289879,0.267060380788449,0.301063776911728,"546"
"hsa04120_Ubiquitin_mediated_proteolysis",0.00543478260869565,3.30270219992883,3.23370455289879,0.267060380788449,0.301063776911728,"6921"
"GO:0045892~negative regulation of DNA-templated transcription",0.00655737704918033,3.46089352309158,3.21671486172769,0.0351146091422682,0.0977749540781179,"25855, 3725, 6464, 8314"
"GO:0007417~central nervous system development",0.00540540540540541,3.27927620041153,3.21109123434705,0.268668114483603,0.302659720104473,"2934"
"GO:0000226~microtubule cytoskeleton organization",0.0053475935828877,3.23339952994636,3.16680032076985,0.271873254703116,0.306051606722937,"203068"
"KW-0498~Mitosis",0.00600600600600601,3.26486847612045,3.14510990761389,0.132795144415415,0.189056140558892,"57542, 989"
"GO:0031267~small GTPase binding",0.00598802395209581,3.25348138944065,3.13437574410668,0.133530561695831,0.189887019574734,"23299, 54453"
"GO:0000209~protein polyubiquitination",0.00529100529100529,3.18877889593866,3.12371460211992,0.275064673325241,0.309202514379871,"57542"
"R-HSA-166016~Toll Like Receptor 4 (TLR4) Cascade",0.00529100529100529,3.18877889593866,3.12371460211992,0.275064673325241,0.309202514379871,"3725"
"R-HSA-983168~Antigen processing: Ubiquitination & Proteasome degradation",0.00595238095238095,3.23094028157215,3.11312573906188,0.135004278348071,0.190822190741309,"57542, 6921"
"GO:0010628~positive regulation of gene expression",0.00616016427104723,3.25265058660177,3.08178554705791,0.0731601780622415,0.138115802722602,"1786, 2335, 2934"
"R-HSA-162587~HIV Life Cycle",0.00523560209424084,3.1453635625686,3.08178554705791,0.278242427700998,0.312551722064699,"6921"
"hsa04010_MAPK_signaling_pathway",0.00586510263929619,3.17591068671822,3.06124031007752,0.138705038332433,0.194829893415254,"3725, 9448"
"R-HSA-9018519~Estrogen-dependent gene expression",0.00518134715025907,3.10310552110681,3.04096719544124,0.281406574947528,0.315431552003772,"3725"
"WP4666:Hepatitis B infection",0.00518134715025907,3.10310552110681,3.04096719544124,0.281406574947528,0.315431552003772,"3725"
"GO:0031625~ubiquitin protein ligase binding",0.00581395348837209,3.14377021684399,3.03093100007675,0.140936495054077,0.19673686112066,"203068, 3725"
"R-HSA-1852241~Organelle biogenesis and maintenance",0.00579710144927536,3.13319860106345,3.02096083231334,0.141682104065984,0.196847425130098,"203068, 5310"
"R-HSA-8953897~Cellular responses to stimuli",0.00629590766002099,3.34835210577876,3.00776886361328,0.0137945486098226,0.0664838183763929,"2335, 3725, 529, 6464, 6921, 9448"
"GO:0072659~protein localization to plasma membrane",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"10484"
"GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"10672"
"GO:0140584~chromatin extrusion motor activity",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"546"
"GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"546"
"GO:0140849~ATP-dependent H2AZ histone chaperone activity",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"546"
"R-HSA-8957322~Metabolism of steroids",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"10484"
"WP1984:Integrated breast cancer pathway",0.00512820512820513,3.06195930138582,3.00121599027208,0.284557171949017,0.317158488678678,"3725"
"R-HSA-1169410~Antiviral mechanism by IFN-stimulated genes",0.00510204081632653,3.04178956639823,2.98172757475083,0.286127406820708,0.318683246042005,"5335"
"R-HSA-162582~Signal Transduction",0.00642722117202268,4.29683078244566,2.98058907624959,1.57448935422655e-05,0.00137855290125614,"10018, 10094, 10672, 10818, 1786, 182, 2335, 3725, 4638, 4659, 529, 5335, 6198, 63916, 6464, 7077, 989"
"GO:0007010~cytoskeleton organization",0.0050761421319797,3.02188960091649,2.96249062265566,0.287694275357624,0.319750478112564,"54014"
"GO:0061775~cohesin loader activity",0.0050761421319797,3.02188960091649,2.96249062265566,0.287694275357624,0.319750478112564,"546"
"R-HSA-9730414~MITF-M-regulated melanocyte development",0.0050761421319797,3.02188960091649,2.96249062265566,0.287694275357624,0.319750478112564,"529"
"GO:0043065~positive regulation of apoptotic process",0.00568181818181818,3.06112293558608,2.95296492933523,0.146925697375807,0.200926597634958,"10018, 3725"
"R-HSA-418555~G alpha (s) signalling events",0.0050251256281407,2.98284905509305,2.92475188860909,0.290817941594407,0.322312992934448,"2335"
"R-HSA-9711097~Cellular response to starvation",0.0050251256281407,2.98284905509305,2.92475188860909,0.290817941594407,0.322312992934448,"529"
"R-HSA-9013148~CDC42 GTPase cycle",0.0050251256281407,2.98284905509305,2.92475188860909,0.290817941594407,0.322312992934448,"10672"
"WP706:Sudden infant death syndrome SIDS susceptibility pathways",0.0050251256281407,2.98284905509305,2.92475188860909,0.290817941594407,0.322312992934448,"3725"
"R-HSA-109582~Hemostasis",0.00597907324364723,3.12506912315938,2.91546696197859,0.047537880138516,0.111987592075189,"10672, 2335, 5335, 6464"
"GO:0006334~nucleosome assembly",0.005,2.9637020705559,2.90624080070651,0.29237475334198,0.323356218432954,"546"
"hsa04110_Cell_cycle",0.005,2.9637020705559,2.90624080070651,0.29237475334198,0.323356218432954,"546"
"R-HSA-9010553~Regulation of expression of SLITs and ROBOs",0.00497512437810945,2.94479762483292,2.8879625566769,0.29392822685024,0.324618700431659,"6921"
"KW-0112~Calmodulin-binding",0.00497512437810945,2.94479762483292,2.8879625566769,0.29392822685024,0.324618700431659,"4638"
"GO:0045296~cadherin binding",0.00555555555555556,2.98265386539053,2.87890938251804,0.152968270920481,0.2056979479272,"3939, 989"
"GO:0005178~integrin binding",0.00495049504950495,2.92613112576373,2.86991279069767,0.295478369107231,0.325873974606716,"2335"
"R-HSA-9006936~Signaling by TGFB family members",0.00495049504950495,2.92613112576373,2.86991279069767,0.295478369107231,0.325873974606716,"7077"
"GO:0008104~protein localization",0.00492610837438424,2.90769809538392,2.85208724541384,0.297025187086725,0.327350835558517,"989"
"R-HSA-2262752~Cellular responses to stress",0.00593119810201661,3.10854967027455,2.85208724541384,0.0297937058704058,0.089249225759137,"3725, 529, 6464, 6921, 9448"
"R-HSA-1474244~Extracellular matrix organization",0.00550964187327824,2.9542399872929,2.85208724541384,0.155247275782659,0.208052471627101,"2335, 7077"
"GO:0015031~protein transport",0.00570342205323194,2.98399172166736,2.8344817685903,0.0888409678957279,0.153449421677166,"10484, 23299, 8675"
"GO:0008083~growth factor activity",0.00490196078431373,2.88949416660766,2.8344817685903,0.298568687748249,0.328363050866183,"182"
"GO:0003689~DNA clamp loader activity",0.00490196078431373,2.88949416660766,2.8344817685903,0.298568687748249,0.328363050866183,"546"
"R-HSA-199977~ER to Golgi Anterograde Transport",0.00490196078431373,2.88949416660766,2.8344817685903,0.298568687748249,0.328363050866183,"10484"
"hsa05161_Hepatitis_B",0.0048780487804878,2.87151508001491,2.81709230988729,0.300108878037113,0.329826772514986,"3725"
"WP3929:Chemokine signaling",0.00483091787439614,2.83621491544353,2.78294573643411,0.303179355207202,0.332969103697945,"6464"
"GO:0042742~defense response to bacterium",0.00480769230769231,2.81888582940428,2.7661810030821,0.304709655908229,0.334416725425744,"6464"
"GO:0043066~negative regulation of apoptotic process",0.00556586270871985,2.90383307153371,2.76063755417812,0.0943629318031467,0.157371407959533,"6198, 6464, 9448"
"GO:0032259~methylation",0.004739336492891,2.76813651958954,2.71707719829366,0.309280889097881,0.339197412121267,"1786"
"GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules",0.00471698113207547,2.75154756167111,2.70109439124487,0.310798100058689,0.340624343318842,"5310"
"GO:0007283~spermatogenesis",0.00543478260869565,2.82776915718922,2.69054324127907,0.100025620298887,0.158863906406898,"10018, 546, 989"
"KW-0131~Cell cycle",0.00554016620498615,2.87317950195416,2.68923014062447,0.0605509501277533,0.127977640651835,"2079, 57542, 6198, 989"
"hsa04141_Protein_processing_in_endoplasmic_reticulum",0.00469483568075117,2.73523649206573,2.68529851761186,0.312312055700961,0.342045726049142,"10484"
"R-HSA-168898~Toll-like Receptor Cascades",0.00467289719626168,2.71911560286702,2.66968631692807,0.313822762843337,0.34322322986891,"3725"
"KW-0788~Thiol protease",0.00467289719626168,2.71911560286702,2.66968631692807,0.313822762843337,0.34322322986891,"8314"
"KW-0945~Host-virus interaction",0.00548696844993141,2.84282081838936,2.66194809571958,0.0623998588342193,0.129674798636113,"5335, 55697, 6464, 6921"
"GO:1902600~proton transmembrane transport",0.00465116279069767,2.70318154030143,2.65425460411346,0.315330228290521,0.344393929165531,"529"
"R-HSA-5693532~DNA Double-Strand Break Repair",0.00465116279069767,2.70318154030143,2.65425460411346,0.315330228290521,0.344393929165531,"8314"
"hsa04310_Wnt_signaling_pathway",0.00462962962962963,2.68743103040544,2.63900026730821,0.316834458833313,0.345797165596469,"3725"
"GO:0001666~response to hypoxia",0.00460829493087558,2.67186087686271,2.62392026578073,0.31833546124863,0.346954831900305,"54541"
"GO:0008201~heparin binding",0.00454545454545455,2.62620171215644,2.57969689051476,0.322819167291315,0.351598484900562,"2335"
"R-HSA-3108232~SUMO E3 ligases SUMOylate target proteins",0.00448430493273543,2.5820577111015,2.53693948348966,0.327274062829199,0.356204366725703,"1786"
"GO:0106310~protein serine kinase activity",0.00495049504950495,2.61320813599255,2.52995066948555,0.187004463204807,0.235239280462032,"6198, 9448"
"R-HSA-1266738~Developmental Biology",0.00536552649228706,2.881349871526,2.5230002555584,0.0122251172462483,0.0628335834008719,"10094, 10818, 182, 3725, 529, 5335, 6464, 6921"
"GO:0061629~RNA polymerase II-specific DNA-binding transcription factor binding",0.00444444444444444,2.55343293026982,2.509213368916,0.33022807665405,0.359171462254508,"3725"
"WP4803:Ciliopathies",0.00442477876106195,2.53929608254725,2.49557633973711,0.331700328607013,0.360275477522159,"5310"
"hsa04360_Axon_guidance",0.00442477876106195,2.53929608254725,2.49557633973711,0.331700328607013,0.360275477522159,"5335"
"hsa05014_Amyotrophic_lateral_sclerosis",0.0048780487804878,2.56957456549321,2.48881326022563,0.191732787541956,0.23887025546729,"203068, 9782"
"GO:0030674~protein-macromolecule adaptor activity",0.00440528634361234,2.52531487027697,2.48208673790069,0.333169419444389,0.361621904300521,"6921"
"WP5420:ADHD and autism ASD pathways",0.00485436893203883,2.55555407048794,2.47539647715163,0.193312716800976,0.240079465467564,"1786, 5335"
"KW-0689~Ribosomal protein",0.0043859649122807,2.51149325800311,2.46874218554639,0.334635355792236,0.362713425535463,"6198"
"WP2877:Vitamin D receptor pathway",0.0043859649122807,2.51149325800311,2.46874218554639,0.334635355792236,0.362713425535463,"7077"
"R-HSA-983712~Ion channel transport",0.00436681222707424,2.49801711417395,2.45554035567715,0.336098144263064,0.363798540768261,"529"
"R-HSA-2990846~SUMOylation",0.00436681222707424,2.49801711417395,2.45554035567715,0.336098144263064,0.363798540768261,"1786"
"GO:0004888~transmembrane signaling receptor activity",0.00434782608695652,2.48453432436272,2.44247897080653,0.337557791455859,0.364627196253896,"4074"
"hsa04621_NOD-like_receptor_signaling_pathway",0.00434782608695652,2.48453432436272,2.44247897080653,0.337557791455859,0.364627196253896,"3725"
"hsa05034_Alcoholism",0.00434782608695652,2.48453432436272,2.44247897080653,0.337557791455859,0.364627196253896,"6464"
"GO:0010467~gene expression",0.00429184549356223,2.44493570750928,2.40411542676245,0.341917951153607,0.368579132023314,"8314"
"R-HSA-948021~Transport to the Golgi and subsequent modification",0.00425531914893617,2.41933271196028,2.37920231353175,0.344809138270548,0.370934608815279,"10484"
"hsa04613_Neutrophil_extracellular_trap_formation",0.00425531914893617,2.41933271196028,2.37920231353175,0.344809138270548,0.370934608815279,"5335"
"GO:0006897~endocytosis",0.00421940928270042,2.3938839139572,2.35480023852117,0.347687917507691,0.373776369708131,"54453"
"R-HSA-1280218~Adaptive Immune System",0.00488400488400488,2.50120162589055,2.35480023852117,0.0888095352342903,0.153449421677166,"10484, 5335, 57542, 6921"
"GO:0098609~cell-cell adhesion",0.00420168067226891,2.38151916002395,2.34278595158994,0.349122670425704,0.374552299925738,"6464"
"R-HSA-8868773~rRNA processing in the nucleus and cytosol",0.00420168067226891,2.38151916002395,2.34278595158994,0.349122670425704,0.374552299925738,"51504"
"KW-0879~Wnt signaling pathway",0.00420168067226891,2.38151916002395,2.34278595158994,0.349122670425704,0.374552299925738,"5310"
"hsa04814_Motor_proteins",0.00418410041841004,2.36927443984211,2.33089363711486,0.350554340852411,0.375832408968299,"203068"
"GO:0070374~positive regulation of ERK1 and ERK2 cascade",0.00416666666666667,2.35714900114157,2.31912144702842,0.351982935253032,0.376851294808953,"6464"
"GO:0051897~positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction",0.00416666666666667,2.35714900114157,2.31912144702842,0.351982935253032,0.376851294808953,"2335"
"GO:0045944~positive regulation of transcription by RNA polymerase II",0.0048820179007323,2.5315018270915,2.31133916029343,0.0431080867432991,0.107497380866202,"182, 3725, 4659, 5310, 546, 8028"
"GO:0016055~Wnt signaling pathway",0.00413223140495868,2.33325219267742,2.29593023255814,0.354830921770779,0.379385028976084,"5310"
"KW-0489~Methyltransferase",0.00413223140495868,2.33325219267742,2.29593023255814,0.354830921770779,0.379385028976084,"1786"
"KW-0343~GTPase activation",0.00411522633744856,2.32147863814667,2.2845076940877,0.356250326752301,0.38038652775178,"54453"
"WP3594:Circadian rhythm genes",0.00411522633744856,2.32147863814667,2.2845076940877,0.356250326752301,0.38038652775178,"3725"
"KW-0970~Cilium biogenesis/degradation",0.00409836065573771,2.30982004294303,2.27319825005756,0.357666681436586,0.381640277551834,"2934"
"R-HSA-9705683~SARS-CoV-2-host interactions",0.00408163265306122,2.2982751179242,2.26200022912132,0.359079992222966,0.382889085076721,"10484"
"GO:0007420~brain development",0.00403225806451613,2.26430882904209,2.22905847821179,0.3633017249917,0.386867242288459,"54541"
"R-HSA-72312~rRNA processing",0.00403225806451613,2.26430882904209,2.22905847821179,0.3633017249917,0.386867242288459,"51504"
"R-HSA-397014~Muscle contraction",0.00401606425702811,2.253204916366,2.21829007976632,0.364702923918224,0.38783522813436,"4638"
"R-HSA-376176~Signaling by ROBO receptors",0.00401606425702811,2.253204916366,2.21829007976632,0.364702923918224,0.38783522813436,"6921"
"R-HSA-9824446~Viral Infection Pathways",0.00460829493087558,2.3465647459849,2.21561421718518,0.105166501230419,0.161831979187132,"10484, 203068, 25855, 6921"
"KW-0132~Cell division",0.0043859649122807,2.27812587119469,2.21294480246568,0.22845973984835,0.267896242560267,"57542, 989"
"R-HSA-68877~Mitotic Prometaphase",0.004,2.24220773805167,2.2076252236136,0.366101110747558,0.389059575548315,"203068"
"GO:0030246~carbohydrate binding",0.00396825396825397,2.22045237078688,2.18660022148394,0.368888473386243,0.391757570119083,"5310"
"GO:0005516~calmodulin binding",0.00395256916996047,2.20972049231283,2.1762371872589,0.370277661799061,0.392968077437926,"4638"
"hsa04015_Rap1_signaling_pathway",0.00393700787401575,2.19939417331545,2.16597191750768,0.37166386332167,0.394173787748958,"5335"
"R-HSA-1483257~Phospholipid metabolism",0.00392156862745098,2.18887731504163,2.15580303526586,0.373047084223588,0.395374717374832,"55697"
"KW-0653~Protein transport",0.00441826215022091,2.24828845005947,2.15580303526586,0.161846526456574,0.213707171481597,"10484, 23299, 8675"
"GO:0007165~signal transduction",0.00451467268623025,2.32207989639662,2.13244294045648,0.0595783286782472,0.126373413185623,"10672, 4659, 54453, 55697, 57826, 6198"
"GO:0010468~regulation of gene expression",0.00384615384615385,2.13781937205974,2.10635801152123,0.379918697958627,0.402387008052954,"546"
"hsa04081_Hormone_signaling",0.00383141762452107,2.12789804007716,2.09673993840926,0.381284166079064,0.403562018630359,"10672"
"GO:0030036~actin cytoskeleton organization",0.00381679389312977,2.11806909155863,2.08720930232558,0.382646697107365,0.404460895131594,"6464"
"R-HSA-162906~HIV Infection",0.00381679389312977,2.11806909155863,2.08720930232558,0.382646697107365,0.404460895131594,"6921"
"GO:0007399~nervous system development",0.00411522633744856,2.12057010741815,2.06375751241181,0.252709258919358,0.289230059591073,"182, 2335"
"GO:0016301~kinase activity",0.00377358490566038,2.08912052956363,2.05913025341537,0.386716729251469,0.407942145448671,"4638"
"R-HSA-8939211~ESR-mediated signaling",0.00377358490566038,2.08912052956363,2.05913025341537,0.386716729251469,0.407942145448671,"3725"
"GO:0038023~signaling receptor activity",0.00374531835205993,2.07025550802484,2.04082687338501,0.389415511288208,0.409692153398008,"55697"
"R-HSA-211859~Biological oxidations",0.00373134328358209,2.06094921067399,2.03179666598065,0.390760548840186,0.410559083314755,"51504"
"hsa05208_Chemical_carcinogenesis",0.00373134328358209,2.06094921067399,2.03179666598065,0.390760548840186,0.410559083314755,"3725"
"GO:0006338~chromatin remodeling",0.00416666666666667,2.10752533438319,2.02582079343365,0.183895774172216,0.232988842679095,"546, 6198, 9448"
"R-HSA-1640170~Cell Cycle",0.00413223140495868,2.08829241645243,2.00810224421995,0.187191167207954,0.235239280462032,"203068, 4659, 546"
"hsa04820_Cytoskeleton_in_muscle_cells",0.00364963503649635,2.0069226349458,1.97925020048115,0.398770208638648,0.418695435585949,"2335"
"GO:0004842~ubiquitin-protein transferase activity",0.00363636363636364,1.99805311963302,1.97075556442759,0.400095114139009,0.419806857445458,"57542"
"GO:0051607~defense response to virus",0.003584229390681,1.96378869292995,1.93749386713767,0.405366277131917,0.424772109547807,"54541"
"GO:0045893~positive regulation of DNA-templated transcription",0.00398406374501992,2.00609996782937,1.93205910173195,0.202214941993302,0.248201517586795,"3725, 57826, 6464"
"GO:0000976~transcription cis-regulatory region binding",0.00357142857142857,1.95540375257265,1.92935313660348,0.406676983000449,0.425762377513784,"3725"
"KW-0010~Activator",0.00396301188903567,1.99444331103789,1.92128052933736,0.204466210406881,0.24997252578712,"1786, 3725, 54014"
"hsa05022_Pathways_of_neurodegeneration",0.00383141762452107,1.95754720495928,1.90929749069284,0.281919136611878,0.315781492040028,"203068, 5335"
"GO:0006366~transcription by RNA polymerase II",0.00353356890459364,1.93067009189714,1.90533629257937,0.410592192046199,0.429391701834645,"546"
"GO:0005509~calcium ion binding",0.00391644908616188,1.96868932359141,1.89746300211416,0.209554084494495,0.254631640064244,"182, 2934, 5335"
"KW-0418~Kinase",0.00386100386100386,1.93807486471023,1.86914265879903,0.215813197795694,0.258058876878615,"4638, 6198, 9448"
"GO:0008284~positive regulation of cell population proliferation",0.00374531835205993,1.90853504670092,1.86282371809991,0.291652886214725,0.323011207782436,"2335, 6464"
"hsa04144_Endocytosis",0.00341296928327645,1.85254728370019,1.82942648012601,0.4234615001412,0.441970413392405,"10094"
"R-HSA-212436~Generic Transcription Pathway",0.00386398763523957,1.94060678504204,1.82796993038068,0.135740805682331,0.191691316985084,"10018, 182, 3725, 54541, 6921"
"GO:0010629~negative regulation of gene expression",0.00340136054421769,1.8450814977834,1.82216685123662,0.424733232750922,0.443004351300763,"1786"
"GO:0042802~identical protein binding",0.00388888888888889,1.98588573571894,1.82216685123662,0.0848372966868244,0.150228741099365,"2335, 3725, 3939, 55697, 6198, 9782, 989"
"R-HSA-556833~Metabolism of lipids",0.00376411543287327,1.88471996555584,1.81975976160487,0.227299708572003,0.266878336747573,"10484, 4074, 55697"
"GO:0009410~response to xenobiotic stimulus",0.00338983050847458,1.83767584162127,1.8149646107179,0.426002225260629,0.444034065483301,"6198"
"R-HSA-597592~Post-translational protein modification",0.00384862091084028,1.94526256720141,1.8101946643034,0.110315385617278,0.167708589203267,"10484, 1786, 2335, 57542, 6921, 8314"
"KW-0833~Ubl conjugation pathway",0.00367647058823529,1.83641224478206,1.77520378806042,0.238326997579782,0.275571055161949,"57542, 6921, 8314"
"R-HSA-1428517~Aerobic respiration and respiratory electron transport",0.00332225913621262,1.7942698910188,1.77291909850049,0.433558960153512,0.451611977000618,"3939"
"WP2059:Alzheimer 39 s disease and miRNA effects",0.00327868852459016,1.76656017963554,1.74595454947387,0.438542707012661,0.456200202146504,"203068"
"WP5124:Alzheimer 39 s disease",0.00327868852459016,1.76656017963554,1.74595454947387,0.438542707012661,0.456200202146504,"203068"
"R-HSA-74160~Gene expression (Transcription)",0.0036607687614399,1.83955205389658,1.71979792700984,0.132074218201335,0.188540731780167,"10018, 1786, 182, 3725, 54541, 6921"
"R-HSA-392499~Metabolism of proteins",0.00367985280588776,1.88450647765674,1.71738586820618,0.0878167880458091,0.152927356862094,"10484, 1786, 2335, 2934, 51504, 57542, 6921, 8314"
"GO:0003676~nucleic acid binding",0.00321543408360129,1.72647837429073,1.70701132532204,0.445938118919335,0.463587384839625,"9782"
"KW-0221~Differentiation",0.00354191263282172,1.76280395672825,1.70701132532204,0.256525441487728,0.292407918236561,"51335, 8314, 989"
"GO:0001227~DNA-binding transcription repressor activity, RNA polymerase II-specific",0.00318471337579618,1.70710255070019,1.68818399452804,0.449600059217879,0.466778454102356,"3725"
"R-HSA-73857~RNA Polymerase II Transcription",0.00352858151023289,1.75508438140541,1.66492402651062,0.178812904953893,0.229113120493769,"10018, 182, 3725, 54541, 6921"
"R-HSA-69278~Cell Cycle, Mitotic",0.00336700336700337,1.6953879341854,1.66070902897515,0.340033288203639,0.366798399869223,"203068, 4659"
"hsa05020_Prion_disease",0.00313479623824451,1.67574480002017,1.65771135924775,0.455650825564425,0.472748980309107,"203068"
"R-HSA-913531~Interferon Signaling",0.00309597523219814,1.65146429164328,1.63411404452537,0.460444614337025,0.477094485335405,"5335"
"GO:0003713~transcription coactivator activity",0.00308641975308642,1.64550208773269,1.62831931387102,0.461636603731985,0.478015300579243,"57826"
"GO:0007166~cell surface receptor signaling pathway",0.00307692307692308,1.63958213605502,1.62256553537678,0.462826020884506,0.478932244854879,"5310"
"R-HSA-72766~Translation",0.00298507462686567,1.58261122003543,1.56718787205334,0.474579905730141,0.490129706048953,"51504"
"GO:0006281~DNA repair",0.00297619047619048,1.57712788915073,1.56185730105996,0.475741383421566,0.491007478894819,"546"
"R-HSA-9006931~Signaling by Nuclear Receptors",0.00294985250737463,1.56090010188514,1.54608096468562,0.479210789953999,0.494264532046795,"3725"
"R-HSA-9694516~SARS-CoV-2 Infection",0.00293255131964809,1.55026303622121,1.53573928599207,0.481511258255038,0.496312454551956,"10484"
"KW-0687~Ribonucleoprotein",0.00292397660818713,1.54499785375358,1.53062015503876,0.482657767351769,0.497169046631626,"6198"
"KW-0744~Spermatogenesis",0.00291545189504373,1.53976776622962,1.52553503824461,0.483801800059605,0.49802197053817,"989"
"R-HSA-5688426~Deubiquitination",0.00288184438040346,1.51919147270727,1.5055280213496,0.488353271276233,0.502379083245002,"8314"
"GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process",0.00284090909090909,1.49422528253207,1.48124531132783,0.493987514985467,0.50751259688207,"57542"
"hsa05016_Huntington_disease",0.00284090909090909,1.49422528253207,1.48124531132783,0.493987514985467,0.50751259688207,"203068"
"WP2882:Nuclear receptors meta pathway",0.00280898876404494,1.47482761432698,1.46237594430455,0.49845123517455,0.511764916374652,"3725"
"R-HSA-446203~Asparagine N-linked glycosylation",0.00280112044817927,1.47005548291328,1.4577334809893,0.499561141864247,0.512570546600295,"10484"
"KW-0678~Repressor",0.00297619047619048,1.47909487362199,1.45542328529835,0.401454497014499,0.420952952291983,"1786, 25855"
"GO:0000122~negative regulation of transcription by RNA polymerase II",0.0030241935483871,1.48200293381339,1.44701485245261,0.34358668511708,0.370124822791879,"1786, 25855, 3725"
"R-HSA-388396~GPCR downstream signalling",0.00294550810014728,1.46228075168785,1.43945469125902,0.406851612015076,0.425762377513784,"10672, 2335"
"R-HSA-212165~Epigenetic regulation of gene expression",0.00274725274725275,1.43748369003626,1.42604362270692,0.507263594424526,0.519796765158032,"1786"
"GO:0016787~hydrolase activity",0.00273972602739726,1.4329462554619,1.42162862697098,0.50835444884659,0.520576095764929,"546"
"GO:0005515~protein binding",0.0030925557764524,19.1217979468586,1.42016303044833,2.06290197428549e-06,0.000464447644496275,"10018, 10094, 10484, 10672, 10818, 1786, 182, 203068, 2079, 23299, 2335, 25855, 26099, 2934, 3725, 3939, 4074, 4638, 4659, 51335, 51504, 529, 5310, 5335, 54014, 54541, 546, 55697, 56650, 57542, 57826, 6198, 63916, 6464, 6921, 7077, 8028, 8314, 8675, 9448, 9782, 989"
"R-HSA-73894~DNA Repair",0.00263157894736842,1.36813724043549,1.35853859914683,0.52443695921388,0.536696524494205,"8314"
"KW-0805~Transcription regulation",0.00289495450785773,1.41855081732824,1.34941323492082,0.257167913977502,0.292407918236561,"1786, 25855, 3725, 54014, 546, 6921, 8028"
"KW-9996~Developmental protein",0.00280898876404494,1.36657240145409,1.34003710071487,0.389381563525736,0.409692153398008,"182, 51335, 8314"
"KW-0217~Developmental protein",0.00280898876404494,1.36657240145409,1.34003710071487,0.389381563525736,0.409692153398008,"182, 51335, 8314"
"GO:0044877~protein-containing complex binding",0.00258397932816537,1.33981437949617,1.33097404785979,0.531765156648784,0.543842885709594,"203068"
"KW-0804~Transcription",0.00281576830249397,1.373657983789,1.31196013289037,0.280928798107773,0.315344576793341,"1786, 25855, 3725, 54014, 546, 6921, 8028"
"GO:0030154~cell differentiation",0.00267379679144385,1.31442118814754,1.29897042860432,0.458797646759725,0.475700717956136,"10672, 989"
"GO:0008270~zinc ion binding",0.00276752767527675,1.34130265965064,1.29287483766765,0.317345292183974,0.346115003793732,"10484, 1786, 546, 7077, 8028, 9782"
"R-HSA-372790~Signaling by GPCR",0.0026525198938992,1.30291807700979,1.28803940115464,0.463198300869184,0.47900296730304,"10672, 2335"
"KW-0234~DNA repair",0.0025062656641604,1.29385220569809,1.28623542440232,0.544071976969472,0.556068375942859,"546"
"GO:0003677~DNA binding",0.00270087778528022,1.30264296667269,1.27374770183531,0.385302045275484,0.40699465372263,"1786, 3725, 546, 8028"
"GO:0003723~RNA binding",0.00268636668905306,1.29486914492392,1.26672012830794,0.389352230840626,0.409692153398008,"2079, 3725, 51335, 9782"
"R-HSA-1430728~Metabolism",0.00269905533063428,1.30337484645692,1.26034596480776,0.339309399436866,0.36626822843322,"10484, 3939, 4074, 51504, 5335, 55697"
"GO:0019899~enzyme binding",0.00240963855421687,1.23718206262564,1.23106178689444,0.559990679157184,0.571789071057424,"3725"
"GO:0046982~protein heterodimerization activity",0.00240384615384615,1.23380160959575,1.22777017783858,0.560967367201591,0.572223023113079,"51504"
"GO:0005524~ATP binding",0.00260416666666667,1.25088038189349,1.22695002407917,0.413093039389777,0.431720576974993,"4638, 546, 6198, 9448"
"GO:0005102~signaling receptor binding",0.00238095238095238,1.22045913730322,1.21477790082441,0.564852987708386,0.575813912437527,"2335"
"hsa05010_Alzheimer_disease",0.00231481481481481,1.18207813176171,1.17740011926058,0.576309402309091,0.586733603384449,"203068"
"hsa01100_Metabolic_pathways",0.00249376558603491,1.19192564863587,1.17363845753771,0.447160028337147,0.464551222583615,"1786, 3939, 529, 5335"
"GO:0008285~negative regulation of cell population proliferation",0.00227272727272727,1.15777983948129,1.1537337852051,0.583782780148815,0.593958464502604,"8314"
"GO:0046872~metal ion binding",0.00244755244755245,1.16546213682604,1.13820903880361,0.419397791894845,0.438019165027353,"10484, 10672, 203068, 4638, 546, 7077, 8028"
"R-HSA-68886~M Phase",0.0022075055187638,1.12031744759867,1.11724098907939,0.595653259743744,0.605254376116144,"203068"
"KW-0813~Transport",0.00238891543239369,1.13296873095402,1.11724098907939,0.468212817525117,0.483871082242351,"10484, 23299, 4074, 529, 8675"
"GO:0016887~ATP hydrolysis activity",0.00220264317180617,1.11753388036836,1.11452923910589,0.596552551655972,0.605387521835037,"546"
"KW-0399~Innate immunity",0.00220264317180617,1.11753388036836,1.11452923910589,0.596552551655972,0.605387521835037,"9782"
"GO:0006357~regulation of transcription by RNA polymerase II",0.00232288037166086,1.10093122851772,1.09135126918985,0.504921242373495,0.517733167196245,"3725, 54014, 6921, 8028"
"KW-0227~DNA damage",0.00210970464135021,1.06454534959966,1.06293066322136,0.614133579425544,0.622827877203769,"546"
"GO:0016567~protein ubiquitination",0.00210526315789474,1.06202386820748,1.06047585799452,0.614992703128993,0.623298070823982,"6921"
"KW-0807~Transducer",0.00217864923747277,1.04960770772971,1.04717456445069,0.575179435595827,0.585961726243712,"10672, 5335"
"GO:0007186~G protein-coupled receptor signaling pathway",0.00214132762312634,1.029872074221,1.02841219823433,0.585193119971808,0.5950092626294,"10672, 10818"
"KW-0378~Hydrolase",0.00217391304347826,1.02193342478712,1.01984685510634,0.560179140680624,0.571789071057424,"5335, 546, 57826, 8314"
"KW-0130~Cell adhesion",0.00188323917137476,0.937454122714439,0.939030769962429,0.660234505367136,0.668291316929099,"2335"
"GO:0001228~DNA-binding transcription activator activity, RNA polymerase II-specific",0.00187265917602996,0.931581086112438,0.93330497258461,0.662505704627487,0.670159814180308,"3725"
"KW-0808~Transferase",0.00194552529182879,0.901265480958883,0.910631723374572,0.652662938344015,0.661051922127357,"1786, 4638, 6198, 9448"
"KW-0238~DNA-binding",0.00191296030607365,0.88410717244882,0.89509950587062,0.66644905017971,0.673716294472882,"1786, 3725, 546, 8028"
"GO:0045087~innate immune response",0.00170357751277683,0.838504336594698,0.842543204608492,0.700269253998485,0.707451502757444,"9782"
"KW-0645~Protease",0.00169779286926995,0.835345790977423,0.839462607882318,0.701610329481003,0.708352260898181,"8314"
"GO:0007155~cell adhesion",0.00168350168350168,0.827549737443268,0.831858779912369,0.704937429255106,0.711255690464819,"2335"
"GO:1990837~sequence-specific double-stranded DNA binding",0.00164203612479475,0.80498796266264,0.809851933882942,0.714702800058164,0.720647225138623,"3725"
"GO:0003700~DNA-binding transcription factor activity",0.00156985871271586,0.765921217320324,0.771741254641391,0.732093951682094,0.737711040825435,"3725"
"KW-0560~Oxidoreductase",0.00156494522691706,0.763271187324278,0.769155856803397,0.733295761244868,0.738449916755215,"3939"
"KW-0391~Immunity",0.0014903129657228,0.723166134954937,0.730025511147262,0.751823581392319,0.756624498259447,"9782"
"R-HSA-9709957~Sensory Perception",0.00148148148148148,0.718438543834776,0.725412395752967,0.754049248774588,0.75838009959716,"2934"
"KW-0406~Ion transport",0.00146842878120411,0.711458300402119,0.718601011755286,0.757351239793709,0.761215276731432,"529"
"R-HSA-8953854~Metabolism of RNA",0.00132100396301189,0.633195545060953,0.64221824686941,0.795608128532374,0.799157686785865,"51504"
"R-HSA-382551~Transport of small molecules",0.00130039011703511,0.622336026105144,0.631617670579956,0.801083434102567,0.804144899455825,"529"
"KW-0694~RNA-binding",0.0012970168612192,0.620560910113478,0.62988483746451,0.801981947827789,0.804534404695478,"9782"
"KW-0443~Lipid metabolism",0.00126422250316056,0.603331808485507,0.613065482659049,0.810751823781413,0.812814805521314,"5335"
"KW-0675~Receptor",0.00115473441108545,0.520266173506461,0.543094082213634,0.89326598844096,0.894401015109881,"10818, 4074"
"GO:0006355~regulation of DNA-templated transcription",0.00103412616339193,0.483882276749334,0.496417347580138,0.873232171755369,0.874897585941807,"546"
"GO:0000978~RNA polymerase II cis-regulatory region sequence-specific DNA binding",0.000830564784053156,0.380247004346884,0.395168714726014,0.926535111253771,0.927123387514885,"3725"
"GO:0000981~DNA-binding transcription factor activity, RNA polymerase II-specific",0.000782472613458529,0.356036784262356,0.371509746368631,0.938129753034496,0.938129753034496,"3725"
